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Abstract 
In a multicellular animal, the different functions of cells are dependent on 
their diversity of shapes. Protein phosphorylation and dephosphorylation 
play an important role in altering the cell shape in response to internal and 
external signals. In this study I focused on all kinases to explore the gene 
functions and mechanisms underlying the regulation of cell morphology.  
Using genomic information I have constructed a Drosophila kinase RNAi 
library, which was then used to screen six different cell lines from two 
different tissues of origin for novel genes involved in the generation of cell 
form. In doing so, I identified a group of common regulators of cell 
behaviour and morphology together with a set of cell-type specific kinases. 
Importantly, this analysis also revealed that, when considering the kinome, 
gene expression signatures are a poor measure of cell type specific 
differences in gene function, measured by comparing with the microarray 
data available in our lab. Most significantly,  these  screens  identified  a  
novel role  for Mnb/DYRK1A,  a  kinase  associated with Down’s   
Syndrome,  in  the  regulation  of  actin-based  protrusions  in cell lines 
derived from neuronal lineages.  
Furthermore, I identified a single STE20 kinase Drosophila Tao-1 in the 
core set which was required for the normal morphology of all cell lines  
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examined. The RNAi-mediated depletion of Tao-1 or expression of the 
kinase-dead protein leads to the stabilisation of microtubules and to the 
formation of long microtubule-based protrusions, whereas the 
overexpression of Tao-1 destabilizes microtubules. I also showed in this 
study that Tao-1 acts independently of Par-1 and Tau in this process. 
Instead, Tao-1 appears to function together with EB1 in the regulation of 
microtubule plus end instability at the cell cortex. Two microtubule motor 
proteins, Khc and Khc-73, interact with Tao-1 in a yeast two hybrid screen, 
which hints at a possible role for the transport of Tao-1 along filaments to 
microtubule plus ends and the cell cortex. Although evidence for a direct 
role for Tao-1 in the phosphorylation and/or regulation of EB1 has yet to 
be established, this is to my knowledge first time a kinase has been found 
acting at the cell cortex to regulate microtubule plus end stability. 
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Thesis Organisation  
The work in this thesis has been organized into six chapters. Chapter 1 
gives the necessary background to my research, with a general 
introduction to the cytoskeleton and to RNAi screening. Chapter 2 
provides information on the materials and methods which have been used 
in my PhD project. Chapter 3 describes the results of parallel RNAi 
screens carried out in multiple Drosophila cell lines, and a comparison of 
this data with microarray gene expression data generated in the lab. 
Chapter 4 looks at the function of Mnb/DYRK1A which was identified as a 
cell type specific actin regulator in neuronal cell lines. Chapter 5 details my 
analysis of the Tao-1 kinase which was identified as a key regulator of 
microtubule dynamics in all 6 cell types studied. In the final part of this 
thesis, Chapter 6, I discuss these experimental results and hypothesis in 
the context of other work in the field, and based on this analysis discuss 
ideas for future research in this area. 
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Chapter 1 
General Introduction 
Here I introduce the background related to my research work. This 
introduction consists of two main sections which present, first, the dynamic 
regulation of the cytoskeleton and second, the background to the main 
methodology used in my study. In the first part, two kinds of cytoskeletal 
proteins, actin filaments and microtubules, will be introduced. Microtubule 
dynamic instability will be emphasized. Following the above, STE20 family 
kinases will be briefly discussed because Tao-1 kinase belongs to this 
family and its biological function should be seen in this light.  RNAi and 
high-throughput RNAi screening are main methodologies in my study. The 
principles of these techniques will also be discussed in the second section.  
Finally, the aims of this study will be clarified in this chapter to help to 
make clear the significance of my work. 
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1.1 Cytoskeleton and Cell morphology  
Cells have to maintain their shape, their internal structure and to interact 
mechanically with their environment. This can not be realized without a 
remarkable system of filaments which both support cellular structure and 
generate the forces required to move molecules, complexes and 
organelles to alter cell shape. There are three main types of filaments in 
eukaryotic cells, which together are named the cytoskeleton: actin 
filaments, microtubules and intermediate filaments. Each type of 
cytoskeletal filament is built from smaller protein subunits like actin 
monomers and α/β-tubulin subunits joined end to end. Their assembly and 
disassembly is tightly regulated, so that cytoskeletal organization can 
promptly respond to changing internal and external environments. The 
regulation of the dynamic behavior of these cytoskeletal proteins also 
contributes to each step in the eukaryotic cell cycle, for example, to the 
formation of the mitotic spindle and of the lamellipodium of a migrating 
interphase cell. Thus, the study of the dynamic regulation of cytoskeleton 
will allow us to better understand the mechanisms underlying diverse cell 
behaviors.  
The term ‘morphology’ in biology refers to the outward appearance (shape, 
structure or pattern) of biological system. In this study, when I talk about 
cell morphology, my focus is cell shape, since cell shape is a key element  
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in development and differentiation. Multicellular organisms are composed 
of a variety of specialised tissues, each of which is made up of cells with 
very different shapes. Furthermore, diseases like cancer are characterised 
by defects in cell differentiation and altered cell shapes. In addition, the 
disruption of normal cell form is thought to be one of the causal 
pathological changes in cancer. So, identifying novel genes involved in the 
regulation of cell shape could contribute to the development of new cancer 
diagnostic markers and therapies.  
1.2 Actin-based protrusions 
Actin filaments are two-stranded helical polymers of the protein actin. 
They appear as flexible structures with a diameter of 5-9 nm, and they are 
organized into a variety of filament networks that underlie different 
macroscopic cellular structures. In a motile cell, actin filaments drive 
migration in three steps [6]. First, actin assembly drives the extension of a 
flat membrane extension at the cell leading edge, called a lamellipodium, 
then adhesions are formed within this structure that connect the 
extracellular substrate to the actin cytoskeleton to anchor the protrusion. 
The final step is to move the mass of the cell forward and to retract the 
trailing edge by combining actomyosin contraction and disassembly of 
adhesions at the cell rear [7].   
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1.2.1 The lamellipodium formation 
The lamellipodium is the big flat membrane protrusion driven by the 
extension of actin assembly at cell’s leading edge. A process called 
‘treadmilling’ plays an important role in maintaining the form of the 
lamellipodium. It occurs when one end of an actin filament grows in length 
while the other end shrinks, as actin protein subunits are removed from 
one end of the filament and added at the other end [8], resulting in a 
filament seemingly "moving" across the substratum. This treadmilling of 
actin filaments in the lamellipodium, driven by ATP hydrolysis, is thought to 
be the source of forces moving the leading edge forwards [9]. It has been 
reported that WAVE/Scar are responsible for lamellipodium protrusion in 
response to Rac [10]. 
 
Figure 1-1 Cell migration is dependent on different actin filament 
structures 
Cell migration is initiated by an actin-dependent protrusion of the leading 
edge, which is composed of lamellipodia and filopodia. (This picture was 
modified from Pieta Mattila’s paper [2]).  
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1.2.2 The Filopodia formation 
Filopodia are slim and finger-like cytoplasmic protrusions which extend 
from the leading edge of migrating cells [2].  In the process of cell 
migration, lamellipodia and filopodia are overlapping but their actin 
structures are differently organized and have distinct properties (see 
Figure 1-1). Filopodial protrusions contain 15-20 parallel filaments tightly 
packed into a bundle pushing the membrane [11]. These finger-like 
protrusions are highly dynamic and are controlled by actin monomer 
addition to filament ends at the protrusion tip [12]. Filopodia are also 
thought to have an important role in cell migration, probing their 
microenvironment and serving as “pioneers” during protrusion [13]. The 
elongation of filopodia depends on the precisely regulated polymerization 
of actin [14]. Nobes, Ridley and Hall have suggested that the Rho-GTPase 
Cdc42 controls the formation of filopodia via N-WASP [15]. It has since 
become clear that Formins may play a key role in this process. 
Formins are a group of proteins that can both nucleate new actin filaments 
and associate with the fast-growing end (barbed end) of existing actin 
filaments to form a dynamic cap and which catalyze the processive 
addition of profilin bound actin monomers to this end of the filament [16, 
17]. They can also act as effectors for the Rho small GTPase, Cdc42 [17].  
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1.3 Microtubules and Microtubule dynamic instability 
Microtubules are hollow cylindrical cytoskeletal filaments which cells use 
for many different purposes, such as intracellular trafficking, cell motility 
and division.  
1.3.1 Microtubule structure  
Microtubules were first observed in the 1950's in electron microscopy 
studies of cell sections [18]. They have a diameter of 25 nm and their 
length varies from 200 nanometers to 25 micrometer [19] as shown in 
Figure 1-2. They consist of polymers of α/β-tubulin dimers. These tubulin 
dimers polymerize end to end into protofilaments. The protofilaments are 
bundled to form hollow cylindrical filaments in which 13 dimers are 
arranged in a helical fashion so that each turn of the helix contains 13 
tubulin dimers, each from a different protofilament. 
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Each individual microtubule filament has two ends. One end will have the 
α subunit exposed while the other end will have the β subunit exposed. 
The protofilaments bundle parallel to one another, so in a microtubule 
there is one end, called the plus end, with only β subunits exposed while 
the other end, called the minus end, only has α subunits exposed. The two 
distinct ends of microtubules have different growth rates.  
1.3.2 Microtubule organization in animal cells 
In animal cells, Microtubules are organized by microtubule organizing 
centers (MTOCs), such as centrosomes in the cytoplasm. This is because 
microtubule nucleation is rate limiting at cellular concentrations of 
monomeric tubulin. Contained within the MTOC is another type of tubulin, 
γ-tubulin, which is distinct from the α and β subunits that compose the 
microtubules themselves. γ-tubulin combines with several other proteins to 
Figure 1-2 
Microtubule structure 
and its dynamic 
instability (The picture 
was taken from 
Cheeseman’s nature 
review [3] )  
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form a circular structure known as the ‘γ-tubulin ring complex’ [20, 21]. 
This complex acts as a scaffold for α/β tubulin dimers to begin 
polymerization, functioning as a minus-end nucleator of microtubules [21], 
while microtubule growth continues away from the MTOC, at its plus ends.  
In animals, there are two important types of MTOC. One is the basal body 
associated with cilia and certain intercellular junctions in epithelial cells; 
the other is the centrosome associated with spindle formation. At its core, 
each centrosome has a pair of centrioles. Microtubules are anchored with 
their minus ends embedded in centrosomes, which are thought to function 
as microtubule-organizing centers throughout the cell cycle in animals. 
However, recent data from Jordan Raff’s lab show that Drosophila 
presents an interesting paradox as centrosome-deficient mutant flies can 
develop into viable adults [22].  The Rogers’ lab also found that many 
Drosophila cell types display an altered cycle, in which functional 
centrosomes are only present during cell division. On mitotic exit, 
centrosomes disassemble producing interphase cells containing centrioles 
that lack microtubule-nucleating activity [23]. Furthermore, steady-state 
interphase microtubule levels are not changed by depleting γ-tubulin [23]. 
These recent data suggest that there might be other redundant pathways 
catalysing microtubule nucleation, which are MTOC independent.  
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1.3.3 Microtubule kinetics and its dynamic instability 
Each microtubule filament is a highly dynamic polymer.  As mentioned 
above, it has two distinct ends, called plus ends and minus ends, with 
different growth rates. This is because a linear polymer of protein 
molecule assembles and disassembles by the addition and removal of 
subunits (called monomers) at its ends. The rate of addition of these 
subunits is given by the rate constant kon. The number of monomers that 
are added to the microtubule per second will be proportional to the 
concentration of the free subunit, but the subunits will leave the polymer 
end at a constant rate koff that does not depend on the concentration of 
free subunits. When the microtubule filament grows, subunits are used up, 
and the concentration of free subunits drops until it reaches a constant 
value, called the ‘critical concentration’. At this concentration the rate of 
subunit addition equals the rate of subunit loss. A difference in the rates of 
growth at the two different ends is made possible by changes in the 
conformation of each subunit as it enters the polymer which affects the 
rates at which subunits add to the two ends. In microtubules this is 
achieved by the addition of tubulin dimers entering the microtubule in a 
GTP-bound state. The hydrolysis of GTP in the filament then induces a 
change in conformation so that in a growing microtubule, the plus end 
contains a GTP-tubulin while the minus end of the microtubule contains 
GDP-tubulin. As a result, the rate of elongation is the different at the two  
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ends.  
So, when a microtubule filament grows in the plus end direction, the β 
subunits bound to a molecule of GTP act as a GTP cap. This GTP cap 
protects and stabilizes the plus end so that microtubules depolymerise 
about 100 times faster from an end containing GDP tubulin than from a 
GTP tubulin one [24]. So, when the GTP cap is hydrolized the plus end of 
microtubule undergoes rapid depolymerization and shrinkage [24]. This 
switch from growth to shrinking is called a catastrophe. GTP-bound tubulin 
can bind to the tip of a shrinking microtubule to provide a new cap and to 
protect the microtubule from shrinking, in an process called rescue [25]. In 
cells, because of these dynamics, individual microtubules switch between 
growing and shrinking states in the course of their lifetime (see Figure 1-3). 
This combination of growth, shrinkage and rapid transitions between the 
Figure 1-3 The combination of growth, shrinkage and rapid transitions 
between the two is known as ‘dynamic instability’. The picture was 
modified from Tim Mitchison’s review [1].  
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two is known as ‘dynamic instability’ [1]. Although dynamic instability may 
be more crucial for microtubule plus end function in vivo, both microtubule 
ends exhibit this behavior in vitro [26]. An interesting question might be 
raised if dynamic instability occurs at the minus end.  Current opinion is 
that anchorage of the microtubule minus-ends at centrosomal and non-
centrosomal sites stabilizes the minus end. It is not clear how this will be 
prevented in Drosophila cells without a functional MTOC. Ninein has been 
reported as a non-nucleating microtubule minus-end associated protein 
which may have a dual role as a minus-end capping and anchoring protein 
[27]. 
1.4 Cellular Regulation of Microtubule Instability  
Dynamic instability is very important for cells. It allows microtubules to 
rapidly explore cell space, continuously re-using tubulin monomers as the 
network organisation changes. Although this process consumes energy 
(GTP), filament turnover can be fast, in the order of seconds. This means 
that microtubules can adapt quickly to changes in the environment. So, to 
understand how cells precisely regulate this process will be an essential 
step to understand many cellular activities.   
32
1.4.1 Microtubule-associated proteins (MAPs) – the Yang of 
microtubules 
In traditional Chinese philosophy, the concept of ‘Yin and Yang’ is used to 
describe how opposing forces or two aspects of one thing are 
interconnected and interdependent in the natural world, giving rise to each 
other in turn. The concept lies at the heart of many branches of classical 
Chinese science and philosophy as well as being a primary guideline of 
traditional Chinese medicine. Here, I would like to introduce this concept 
to the regulation of microtubule instability.  
Microtubule-associated proteins (MAPs) are a family of proteins that bind 
microtubules. A large variety of MAPs have been identified in many 
different cell types. The proteins in this family usually share a region which 
can bind to microtubules localized at either their N-terminals or C-
terminals. The MAPs can be divided into 4 groups which are MAP1, MAP2, 
MAP4 and Tau groups.  
MAP1a and MAP1b constitute the MAP1 family. They utilize charged 
interactions to bind to and stabilize microtubules [28]. The C-termini of 
MAP1 family proteins bind microtubules, and the N-terminals bind other 
parts of the cytoskeleton or the plasma membrane to control the 
organisation of microtubules within the cell. MAP1 family proteins are 
mainly expressed in neurons, where they are thought to be important in  
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the formation and development of axons and dendrites [29].  
MAP2 is found primarily in the dendritic extensions of neurons. MAP2 has 
been considered as a hallmark of neuronal differentiation [30] and plays a 
role in stabilizing microtubules.  
MAP4 is expressed in nearly all types of cells. It is responsible for 
stabilization of microtubules. This protein promotes microtubule assembly 
in vivo, and has been shown to counteract interphase microtubule 
catastrophe [31]. Cyclin B was found to interact with this protein, which 
targets cell division cycle 2 (CDC2) kinase to microtubules in mitosis [32]. 
Finally, Tau is the most famous MAP family member because it has been 
implicated in Alzheimer's disease [33]. It is found primarily in neurons, 
where its phosphorylated isofoms bind to tubulin to promote 
polymerization and stabilization of microtubules. Hyperphosphorylation of 
Tau can make them drop off microtubules, leading to disassembly of the 
microtubule. The protein has also been widely used as a marker of 
individual microtubule filaments. 
1.4.2 Microtubule destablizers – the Yin of microtubules 
The Yin-Yang theory always helps us to understand and describe 
opposing aspects in one system or phenomenon. If the above MAPs 
stabilize microtubules can be compared to the Yang aspect in microtubule  
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instability regulation, there should be a Yin aspect to make the system 
balanced, which requires a group of proteins to function as microtubule 
destabilzers. While MAPs bind to lateral side of the polymers to stabilize 
microtubules, these proteins work in multiple ways to destabilize 
microtubules. The most important counter-balance to microtubule 
polymerisation is the intrinsic ability of tubulin in the filament to hydrolyse 
GTP to GDP. This leads to the loss of the GTP cap and to catastrophe. In 
addition, several proteins have been identified that can bind to tubulins 
dimers to inhibit monomer addition at the growing end, and the following 
proteins have been shown to work as destabilizers of microtubules. 
Stathmin/Op18: Stathmin/Op18 was originally identified as an oncoprotein. 
It is a member of a microtubule-destabilizing protein family which has 
been shown to play a critical role in the regulation of mitosis [34]. Stathmin 
has been shown to bind tubulin to inhibit microtubule polymerization [35, 
36] and to promote catastrophe by inducing GTP hydrolysis [37]. 
Stathmin/Op18 is regulated by phosphorylation at four serine residues by 
a number of protein kinases and dual phosphorylation, particularly of 
serines 16 and 63, inhibits the microtubule destabilizing activity of Op18 
[38]. 
Spastin/Katanin: Spastin functions as a microtubule severing enzyme. In 
1991, the Vale lab first showed the evidence with Xenopus egg mitotic  
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extracts that microtubule breakage reflects the action of an enzyme rather 
than just mechanical strain [39]. Two years later McNally identified an 
ATPase that has the function of severing and disassembling stable 
microtubules to form tubulin dimers [40]. Microtubule severing is a hard 
task as the enzyme needs to break both longitudinal and lateral contacts 
in the microtubule lattice. The most significant thing is that the finding of 
this protein demonstrates a novel mechanism for cells to disassemble 
microtubules which utilizes energy from nucleotide hydrolysis to break 
tubulin-tubulin bonds within a microtubule polymer [40]. Using small-angle 
X-ray scattering combined with atomic docking, Katanin was seen in 
hexamers, forming a ring with a prominent central pore and six radiating 
arms that dock onto the microtubule [41].  The Vale lab has come up with 
a working model for Katanin published in 2008, in which Spastin pulls the 
C terminus of tubulin through its central pore, generating a mechanical 
force that destabilizes tubulin-tubulin interactions within the microtubule 
lattice [41]. 
Minispindle/XMAP215: Unlike the other MAPs, XMAP215 has both 
microtubule plus end stabilizing and destabilizing activities.  Gard and 
Kirschner identified this protein in Xenopus egg extracts in 1987 [42]. In 
vitro data in the following years revealed that it inhibits the activity of 
XKCM1 a kinesin-13 family member to suppress catastrophe from  
36
microtubule plus ends [43]. However, XMAP215 and its yeast homologue 
Stu2 can also destabilize microtubules through interfering with tubulin 
addition to microtubule plus ends [44, 45]. Recent data from Ohkura’s lab 
demonstrate Minispindles acts as an anti-pausing factor to exhibit both 
microtubule stabilising and destabilising activities. This is a new 
mechanism for the regulation of microtubule instability [46]. 
Microtubule filaments can work as a track for motor proteins in addition to 
generating movements and forces through the regulation of dynamic 
instability. The major microtubule motor proteins are those of the kinesin 
superfamily, which generally move towards microtubule plus ends and 
dynein which moves towards the minus end. Here, I am going to focus on 
a subset of motor proteins that have effects on the microtubule instability. 
So, Dynein will not be discussed in the following text.  
Kinesin super family proteins (KIFs) are motor proteins that transport 
membranous organelles and macromolecules for cellular functions along 
microtubules. They share a 360 amino acid globular ATPase domain to 
hydrolyze ATP to supply energy for this movement.  However, more recent 
data suggest that some members of this family such as Klp10A and 
Klp67A also function to regulate microtubule instability. For the historical 
reasons the nomenclature can cause confusion as different kinesins have 
different names in various species. In Table 1-1, I try to summarize their  
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reported functions and localization according the most popular and 
systematic nomenclature.  
 
Standardized 
name 
Drosophila 
homology 
Human 
homology Reported  function 
Kinesin-1  Khc  KIF5B  Vesicle transport, conventional 
Kinesin-2 Kif3C  KIF3A/3B  Vesicle-intraflagellar  transport 
Kinesin-3 Unc-104  KIF1A  Organelle  transport 
Kinesin-4 Klp3A  KIF21A/B, 
Organelle transport, chromosome 
movement 
Kinesin-5 Khc-73 KIF11 
Spindle formation, microtubule induced 
cell polarity 
Kinesin-6  Pav  KIF20  Cytokinesis, spindle polarity 
Kinesin-7 Cmet  KIF10  Kinetochore microtubule capture 
Kinesin-8 Klp67A 
KIF18B, 
KIF19A 
Nuclear migration, mitochondrial 
transport and destabilising MT 
Kinesin-9 none  KIF6  Unclear 
Kinesin-10 Nod 
KIF26A, 
KIF26B  Chromosome segregation 
Kinesin-11 none  KIF22  Signal  transduction 
Kinesin-12  Klp54D  KIF12 Organelle  transport 
Kinesin-13 
Klp10A, 
Klp59c MCAK,KinI
Microtubule depolymerising at plus 
end/central motor 
Kinesin-14A Ncd  KIFC1  Chromosome  segregation 
Kinesin-14B none  KIFC2  Organelle  transport 
Table 1-1 Kinesin family members and their homologues 
As I shown in above table, so far two kinesin subfamilies can function as 
microtubule destablisers. These are the kinesin-8 and kinesin-13 families. 
The Kinesin-13 family protein, also known as KinI or Kif2, has been 
reported to promote the catastrophe of the microtubule polymers at its 
plus end. In Drosophila, there are two members in this subfamily- Klp10A 
and Klp59C which functionally cooperate to regulate microtubule plus end 
dynamics in interphase. A model for the mechanism by which these two 
proteins induce microtubule plus end catastrophe has been proposed by 
David Sharp’s lab [47, 48]. In interphase, they suggest that Klp10A can  
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target to the plus end of polymerizing microtubules by directly interacting 
with EB1 [49], whereas Klp59C binds along the lateral side of 
microtubules. When a microtubule pauses for a long time at the cell cortex, 
Klp10A will be inactivated and will drop off from the plus end, which allows 
Klp59C to accumulate at the plus end where it acts to depolymerise 
microtubules [50]. Thus, the hallmark of this process is its reliance on the 
paused state during the microtubule dynamic cycle. It is easy to 
understand how cells could use this mechanism to make microtubule 
dynamics sensitive to spatial information within the cell. 
Kinesin 8 family member Klp67A is present in an active form in the 
nucleus during interphase. It therefore engages with its microtubule 
targets during nuclear envelope breakdown (NEB) at the onset of mitosis.  
The Vale lab also demonstrated that relocalisation of Klp67A to the 
cytoplasm using a nuclear export signal resulted in the disassembly of the 
interphase microtubules [51].  This experiment provides support for the 
hypothesis that this class of kinesins possesses microtubule-destabilizing 
activity, which is regulated by changes in the subcellular localization of the 
protein. Kip3p the yeast homologue of Klp67A has several properties that 
distinguish it from other depolymerising kinesins, such as the kinesin-13 
MCAK. The most important one is that Kip3p depolymerises longer 
microtubules faster than shorter ones, which provides a new mechanism  
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for controlling the lengths of subcellular structures known as  length-
dependent depolymerization [52]. 
1.6 Microtubule plus-end interaction proteins (+TIPs) 
The network of Microtubule polymers in a cell quickly adapts to a new 
internal and external environment. This is because there are many 
microtubule accessory factors in the cytoplasm which form a system to 
precisely control the polymerization and depolymerization of microtubule 
filaments. Apart from the microtubule associated proteins (MAPs) and 
microtubule based motor proteins I mentioned above, there is another 
group of proteins that play an important role in the dynamics of 
microtubules. They regulate the microtubule dynamics through the 
microtubule plus end to guide the growth of the filament network, by 
favouring the growth or catastrophe of individual filaments, depending on 
their local environment in the cytoplasm. They also act as a scaffold for 
other signalling proteins to regulate the polymerization of microtubule 
filaments. These are termed plus-end-interaction proteins (+TIPs). To date, 
two distinct classes of such proteins have been characterized. One is end-
binding proteins and end-binding associating proteins; the other is end-
binding microtubule destabilizers that induce their depolymerization, which 
I discussed in 1.4.1. In the following, I will only focus on the first class.  
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Human  Drosophila S.pombe  S.cerevisiae 
EB1, EB3  EB1  Mal3p  Bim1p 
CLIP-170,CLIP115 CLIP-190  Tip1p  Bik1 
CLASP1, CLASP2  MAST/Orbit  ?  Stu1p 
Table 1-2 Homology in different Organisms for +TIPs 
1.6.1 Microtubule plus-end binding proteins (EB1) 
EB1 (also known as Mal3p in S. pombe and Bim1p in S. cerevisiae) was 
first identified as an adenomatous polyosis coli (APC) interacting protein 
which can bind to the plus-end of growing microtubule polymers in 1995 
[53]. In 1998, Morrison and colleagues defined its subcellular localization. 
In interphase, EB1 was found associated with microtubules along their full 
length but was particularly concentrated at their tips. During early mitosis, 
EB1 was localized to centrosomes and their associated microtubules. 
During cytokinesis EB1 was strongly associated with the midbody 
microtubules [54]. Importantly, immunofluorescence microscope images 
suggest the native EB1 is in punctate structures hinting that EB1 may 
work as part of a large protein complex [55]. Since then, GFP-EB1 fusions 
have been widely used as a microtubule plus end marker to visualize 
microtubule dynamics in living cells. In 2000, EB1 was supposed to 
function in the recruitment of tubulin subunits at microtubule plus ends [56]. 
In addition, further work done in 2002 revealed that EB1 can stimulate the 
growth of microtubules at their plus ends and is necessary for the long- 
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range and dynamic microtubule filament ‘search-capture’ process [57]. 
This ‘search-and-capture’ mechanism was first proposed in 1986 by 
Mitchison to explain the way in which the inter-conversion between the 
growth and shrinking of microtubule plus ends, could enable microtubules 
to search for cellular space to interact with and capture target structures 
(e.g. plasma membranes, chromosomes, organelles etc.); a process that 
is followed by stabilization and reorientation of the microtubule-based 
cytoskeleton [58]. Current opinion favours this model. In addition, EB1 can 
control the distribution of other proteins, as Goshima et al. reported in S2 
cells, where EB1 mediates the relocation of the minus end microtubule 
motor protein Ncd (kinesin-14 member function during chromosome 
segregation process ) to microtubule plus ends [59].  
1.6.2 Cytoplasmic linker proteins (CLIPs) and CLIP-associating 
protein (CLASPs) 
The first identified member of the CLIP family of proteins was CLIP-170 
which functions to protect the microtubule against catastrophe [60]. CLIP 
family members include the neural-specific protein CLIP-115, CLIP-170 
and its homologues CLIP-190 in Drosophila and Tip1p in yeast. CLIPs 
localize at the microtubule plus-end and associate with EB1. CLIP’s 
localisation to the plus ends of growing microtubules is maintained by its 
binding to the newly polymerised GTP-cap. CLIPs are then released from  
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the microtubule lattice once the microtubule has aged. Once bound at the 
plus end, CLIP works together with EB1 to regulate microtubule dynamics 
by stabilizing the plus end [61].  
CLIP-associating proteins (CLASPs) were firstly identified as interacting 
partners of CLIPs in a yeast two-hybrid analysis in 2001 [62]. In interphase, 
CLASPs localize to the Golgi apparatus and at the distal ends of 
microtubules [62]. Overexpression of CLASPs in COS-1 cells can stabilize 
microtubules. In contrast, injecting anti-CLASP antibodies suppresses the 
formation of stabilized microtubules in Hela cells [62, 63]. The middle part 
of CLASP binds directly to EB1 and to microtubules [63]. Currently, CLIPs 
and CLASPs are thought to mediate interactions between microtubule 
plus ends and the cell cortex and to act as local rescue factors through 
forming a complex with EB1 at microtubule tips [61]. 
In the following paragraph, STE20 family kinases will be briefly discussed 
because Tao-1 kinase the most important hit in my screen to regulate the 
cell shape belongs to this family, and it is necessary to know the history of 
this kinase family to help us to understand Tao-1’s biological function. 
1.7 STE20 kinase family  
STE20 protein kinases share a typical Serine/Threonine kinase domain. 
They take their name from budding yeast Ste20p (sterile 20 protein)  
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kinase, the first member of this family to be identified. There are about 11 
Ste20 family members in Drosophila and 30 Ste20 kinases in mammals 
(see Figure 1-4) [5]. Two subgroups have been identified based on the 
location of the Serine/threonine kinase domain: the Germinal Center 
Kinases (GCKs) with a N-terminal kinase domain and p21-activated 
kinases (Paks) with a C-terminal kinase domain. STE20 kinases have 
been reported to be involved in many important intracellular activities such 
as cell division through the MAPK pathway, apoptosis and the regulation 
of cytoskeletal remodelling. 
 
Many findings have confirmed that many Ste20 group kinases are able to 
activate the mitogen-activated protein kinase (MAPK) signal cascade [5, 
64, 65].  The MAPK pathway responds to the binding of growth factors to 
Figure 1-4 Phylogenetic 
relations among STE20 family 
kinases. 
Letters in red shows the 
Drosophila homology; letters in 
black shows the mammalian 
members. Drosophila Tao-1 has 
been circled in red. (The picture 
was modified from Dan’s review 
in Trends in  cell biology [5])  
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receptors in the cell membrane, e.g. EGF to EGFR. The basic pathway 
has been shown in the Figure 1-5, and STE20 kinase works as the 
upstream regulator of mitogen-activated protein kinase by phosphorylation. 
In many cases, the activation of this pathway leads to cell growth and cell 
division.  
 
 
Several STE20 group kinases have also been reported to be directly 
involved in either inducing or preventing apoptosis. For example, in a well-
studied apoptosis pathway, activation of Fas by ligand binding induces a 
sequential cleavage of caspases. Downstream effectors like caspase-3 
Figure 1-5 STE20 kinase family can active MAPK pathway. (The 
picture was modified from the website picture at 
http://en.wikipedia.org/wiki/File:MAPKpathway.png)  
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then activate an Ste20 kinase, such as Mst1, Mst2, Hpk1 and Slk, which 
are known to be inducers of apoptosis [66, 67] to promote apoptosis. 
STE20 group kinases have also been involved in morphogenesis and 
cytoskeletal rearrangement. The most well-known subgroup with this 
function is the Pak family. These proteins are characterised by having a 
Cdc42/Rac binding domain. The Pak I subfamily regulates the actin 
cytoskeleton by signaling downstream of the small GTPases,  Cdc42 and 
Rac. Frost and colleagues found that Pak1 induces two types of 
morphological changes [68]. They showed that Pak1 kinase activity is 
important for the disassembly of focal adhesions, and that kinase-
defective Pak1 promotes lamellipodia formation and membrane ruffling 
[69]. The other subgroup of the STE20 kinase family which has been 
reported to affect the cytoskeleton is GCK-IV, whose best know 
representative is Misshapen (Msn). Drosophila Msn has been reported to 
regulate dorsal closure through a JNK MAPK pathway [70] and axon 
targeting in vivo [71]. The human orthologue of Msn, NIK, was recently 
reported to phosphorylate ERM proteins at the distal margins of 
lamellipodia [72], as a novel mechanism that allows cells to control 
membrane protrusion and cell morphology in response to growth factors.  
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1.8 Background to methodology 
1.8.1 RNA interference (RNAi) 
Cells in culture have long been used as models for studying the function of 
proteins. However, until recently it was not possible to use them as a 
system in which to study loss of function genetics. This changed with the 
discovery of gene silencing and RNAi. The earliest gene silencing 
phenomenon, termed co-suppression, was first reported in 1990 [73]. 
Work over subsequent years identified similar silencing in a wide-variety of 
yeast, plants and animals. The impact of this work has been so important 
that 2006 year's Nobel Prize in Physiology or Medicine was shared by 
Andrew Z. Fire and Craig C. Mello for their discovery that silencing 
operates on a post-transcriptional level and is mediated by double-
stranded RNA, published in their joint paper of 1998 [74]. Their discovery 
revealed a new mechanism for gene regulation, and the biochemical 
machinery involved plays a key role in many essential cellular processes. 
Transcripts with double-stranded character (microRNAs) synthesized 
within the cell are now know to regulate gene activity by an RNAi-like 
mechanism, through the inhibition of translation. RNAi has also been 
shown to protect plants and invertebrates cells against viral infections [75] 
and may have a similar function in metazoa, and ensures genome stability 
by keeping mobile elements silent [76].   
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Today, double-stranded RNA mediated RNA interference of gene 
expression (RNAi) serves as a powerful tool for determining protein 
function in a variety of organisms including C. elegans, Drosophila, mouse 
embryos, and mammalian cells. The present understanding of the 
mechanisms underlying dsRNA-induced gene silencing are largely derived 
from genetic studies in C. elegans and plants and from biochemical 
studies in Drosophila extracts [77]. Studies in Drosophila extracts showed 
how long dsRNA substrates could be cleaved into short interfering dsRNA 
species [78]. The process is initiated by a cytoplasmic RNAse III family 
double-stranded RNA-specific endoribonuclease, Dicer. It cleaves long 
dsRNA into short 21-23nt dsRNA fragments to initiate RNAi (see Figure 1-
6). Each dsRNA fragment has a characteristic 2bp 3OH’ overhang and a 
recessed 5’ end phosphate at each end. In order to induce silencing, 
these small double-stranded RNA duplexes bind to form what is known as 
the RNA-Induced Silencing Complex, or RISC. ATP-depending unwinding 
of the small RNA duplex is required to discard one of the strands of the 
small double-strand RNA duplex. The activated RISC complex containing 
an Argonaute family endonuclease bound to a small single stranded guide 
RNA then targets the homologous transcripts by base pairing interactions, 
cleaving the mRNA ~10 nucleotides from the 5' terminus of the small RNA. 
This mRNA is degraded resulting in the eventual loss of the corresponding 
protein. The entire process is restricted to the cytoplasm  [79-81].   
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Although originally described as a post-transcriptional mechanism, RNAi 
silencing has now been proven to work on many levels. In plants, 
exposure to dsRNA induces the methylation of genomic DNA homologous 
to the trigger. If the trigger shares sequence with a promoter, the targeted 
gene can become transcriptionally silenced [10]. Studies in Drosophila 
Figure 1-6 The two-step mechanism of RNA-mediated interference in 
the Drosophila cell cytoplasm.  
The initiation step: Long dsRNAs are cleaved to for 21-23nt siRNAs by 
Dicer. The effector step. siRNAs are bound by the RISC complex, 
which cleaves the sense strand and binds the anti-sense strand, using 
it as a guide to target homologous mRNAs for degradation. The picture 
was modified from Hannon’s review [4].  
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have suggested that the RNAi machinery may also affect gene expression 
at the level of chromatin structure. Some reports suggested that RNAi-
dependent methylation of genomic DNA causes heritable alterations in 
gene transcription [82]. Finally, miRNAs, the endogenously encoded 
inducers of the RNAi machinery inhibit protein synthesis by binding to the 
3’ UTR of mRNAs without inducing mRNA degradation [83]. 
1.8.2 High-throughput RNAi Screening using Drosophila cell 
lines 
Why fly cells? With the discovery of RNAi, the use of cultured Drosophila 
cells has several advantages as a model system in which to do cell 
biology. First, there is less genetic redundancy in Drosophila than in 
mammalian systems even though many signaling transduction pathways 
and other cellular processes are highly conserved from Drosophila to 
mammals. Second, many Drosophila cell lines have been established 
which are easy to grow, at room temperature in normal CO2, which are 
ideal for use in studying various cellular processes [84]. Third, results 
obtained from cell culture studies can be confirmed in the whole organism, 
because Drosophila is also amenable to RNAi analyses and genetics at 
the organismal level. Fourth, the use of dsRNA to silence expression of 
specific genes in Drosophila cell culture is cheap, technically simple, 
efficacious, and highly reproducible [85] compared to that in mammalian  
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cells. This is because Drosophila do not respond to dsRNA with an 
interferon response. Instead, dsRNAs are efficiently internalized by the 
cells, thereby circumventing the problems generated by variable 
transfection efficiencies. Finally, the gene-silencing effect can be sustained 
for many cell divisions, as long as the protein of interest is not necessary 
for cell survival [86]. Therefore, RNAi in Drosophila cell culture provides a 
highly effective method for determining the function of proteins identified in 
the Drosophila genome sequencing project, as well as for deciphering the 
functions of mammalian proteins that have Drosophila homologues.  
RNAi is often used for small-scale gene function studies. Tissue culture 
cells have also provided a powerful system for studying many fundamental 
problems in signaling transduction, cell differentiation and cell morphology. 
With the availability of complete genomic sequence, RNAi provides a 
cheap, effective and rapid approach to study gene functions on a large 
scale.  A turning point came with the emergence of high-throughput RNAi 
screening in Drosophila cells, with the help of simple robotics, liquid 
handling devices, sensitive automated microscopes, and control software 
and data processing tools. In addition, progress in screening technologies 
and data analysis now allows the adaptation of screening methods to 
analyse more complex cellular processes [87, 88]. A typical HT RNAi 
screening consists of several key steps. First of all, a suitable dsRNA  
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library needs to be generated, which targets all the genes of interest. 
Second, a choice of cell type and assay conditions needs to be carefully 
considered, and positive and negative controls designed and tested. 
Finally, data acquisition and analysis are very important steps that should 
be considered before embarking on the screen. A typical data analysis 
process includes phenotype annotation, data normalization and a 
statistical analysis.  
RNAi screens can also be refined through many of the same screening 
strategies that have been developed and perfected for decades in classic 
genetic screens. Particularly powerful are modifier screens [89], whereby 
RNAi is used to identify genes and pathways that, when silenced, can 
either enhance or suppress a given phenotype of interest. The phenotype 
to be modified can be the result of an initial drug treatment [90]. 
1.9 Aims of the Thesis 
Different cell lines exhibit different cell shapes, which are generated by the 
organisation of the actin and microtubule networks. Kinases play very 
important roles in this process because many signal-transducing cascades 
result in the phosphorylation of proteins which regulate tubulin and actin 
dynamics to alter cell shape. Thus, in this study of morphogenesis I 
focused on all Drosophila kinases and used high-throughout RNAi screens 
to reveal novel genes involved in the regulation of cell shape in 6 different  
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Drosophila cell lines from 2 different kinds of tissues. This enabled me to 
identify generic and cell type specific regulators of the cytoskeleton. I then 
chose to characterize the function of two of these novel cytoskeletal 
regulators in detail. 
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Chapter 2  
Methods and Materials 
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2.1 Selection of Drosophila kinases 
In biochemical terms, a kinase is a type of enzyme that transfers 
phosphate groups from high-energy donor molecules to specific target 
molecules; this process is termed phosphorylation. Drosophila kinases 
consist of several subgroups as shown in the Figure 2-1. Protein Kinases 
are the largest subgroups, based on the total set of predicted proteins that 
were identified in the Drosophila genome using automated gene predictor 
methods [91] and published references [92]. In this study, 265 kinases in 
total were selected to make the kinase library. The percentage of each 
different subgroup is also shown in the Figure 2-1. 
Using genomic information, I constructed a Drosophila kinase RNAi library, 
which was then used to screen six different cell lines from two different 
tissues originating from embryonic haemocytes and CNS tissues for novel 
genes involved in the generation of cell form. In doing so, I identified 
several regulators of cell behaviour and morphology across all cell lines, 
together with a set of cell-type specific kinases. Importantly, this analysis 
also revealed that, when considering the kinome, gene expression 
signatures are a poor measure of cell type specific differences in gene 
function.  
55
 
2.2 Genomic DNA Preparation 
Approximately 30 pregnant female adult (WT) flies were homogenised in 
an eppendorf tube and genomic DNA was recovered using the Puregene 
DNA Isolation kit (Lot No. GS7907), following the protocol as described in 
the manual.  
2.3 dsRNA Synthesis and Kinase library generation 
Pairs of gene-specific primers (QIAGEN) were taken from FLIGHT 
database [93] or designed de novo using the E-RNAi primer design tool 
[94]. Each primer was designed to be ~21bp in length before addition of a 
Figure 2-1 Subgroups and percentage of kinases in Drosophila 
dsRNA library  
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T7 tag ((TAATACGACTCACTATAGGG). Templates for the kinome RNAi 
library, targeting 265 Drosophila kinases and kinase regulatory subunits, 
were generated by PCR using HotSarTaq DNA polymerase (QIAGEN) in 
200 μl PCR tubes (Appleton Woods TA571). PCR was carried out using 
the following program: 
1)  95 ºC  15min 
2)  94 ºC  30sec 
3)  55 ºC  30sec 
4)  72 ºC  30sec 
5)  go to step 2 for 29 cycles 
6)  72 ºC  10min 
7)  4 ºC   hold 
PCR success was confirmed using a 1% agarose DNA gel in 1xTAE. 
GeneRuler 1kb ladder (Fermentas) was used to confirm the size of bands 
obtained. DsRNA synthesis was performed using the T7 MegaScript kit 
(Ambion) according the manual. RNA preparations were purified using 
Multiscreen PCR purification kit (Millipore) attached to a vacuum pump 
with 1xTE buffer (pH=8.0). Purified RNAs were annealed by heating at 
65°C for 10 minutes and cooling slowly. PCR and dsRNA synthesis was 
performed in 96-well plates and dsRNA concentrations were adjusted to 1 
μg/μl before aliquoting into 384-well assay plates using a Beckman 
Biomek FX robot. 300 ng dsRNA of each kinase was added in 5 μl PBS to 
give a final concentration of 0.03 μg/ul in each well in 384-well plate.  
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2.4 Cell culture and cell lines used in the study 
Six Drosophila cell lines were used in the parallel RNAi screening study. 
Kc167 and S2R+ cells were grown in Schneider's medium (Invitrogen) 
with 10% heat-inactivated fetal bovine serum (JRH Biosciences) and 1% 
penicillin-streptomycin (Sigma) at 24°C in treated culture flasks (Falcon 
from BD Biosciences). S2R+ cells were removed from culture flasks using 
Trypsin-EDTA (Invitrogen). S2 cells were grown in InsectExpress media 
with L-Glutamin (PAA Laboratories). The BG2-c2, BG3-c2, BG3-c1 cell 
lines were cultured with Shields and Lang M3 insect medium (Sigma) with 
FBS and antibiotics (1% GIBCO Penicillin and Streptomycin Lot412045). 
M3 media was supplemented with insulin for BG3-c2 (10 μg/ml) and BG3-
c1 (5 μg/ml) cells. Cell lines used in this study are listed in the Table 2-1. 
 cell  lines  origination  Media 
experimental 
purpose 
original 
source 
1 S2 
embryonic 
haemocytes 
InsectExpress 
 (PAA 
Laboratories) 
parellel RNAi 
screening Invitrogen 
2 Kc 
embryonic 
haemocytes  M3(Sigma) 
parellel RNAi 
screening 
Baum's 
lab 
3 S2R+ 
embryonic 
haemocytes M3(Sigma) 
parellel RNAi 
screening 
Baum's 
lab 
4 BG2 
neuronal 
tissue M3(Sigma) 
parellel RNAi 
screening 
Baum's 
lab 
5 BG3-C1 
neuronal 
tissue M3(Sigma) 
parellel RNAi 
screening 
Baum's 
lab 
6 BG3-C2 
neuronal 
tissue M3(Sigma) 
parellel RNAi 
screening 
Baum's 
lab 
7 
pMT-GFP-
EB1 S2 
embryonic 
haemocytes M3(Sigma) 
MT dynamic 
study DGRC 
8 
Act5c-
GFP-
Tubulin S2 
embryonic 
haemocytes M3(Sigma) 
MT dynamic 
study DGRC 
Table 2-1 Different cell lines used in either parallel RNAi screening or in  
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microtubule dynamic studies. 
Two modified Drosophila S2 cell lines were used in the study of 
microtubule dynamic regulation: pMT-GFP-EB1 S2 and Act5c-GFP-
Tubulin S2 (from DGRC). Both grow in 10% FBS M3 media with 1% P/S 
antibiotic (Sigma). 0.5 mg/ml G418 was added to inhibit the growth of non-
expressing cells. 
Cells stocks were stored in liquid nitrogen. For freezing, 1x10
7 cells were 
suspended in 1 ml of ice-cold 10% (v/v) DMSO and 90% (v/v) FBS and 
placed in cryovials (Corning) in an isopropanol cell freezer (Amersham) 
and frozen gradually (-1°C/hour) to -80°C. After 24 hours, cryovials were 
transferred to liquid nitrogen for long term storage. Cells were thawed 
rapidly in a water bath at 37°C. Just before cells were thawed, they were 
mixed with 5 ml of ice-cold medium and centrifuged at 4°C. DMSO 
containing supernatant was removed by aspiration and the cell pellet was 
re-suspended in 5 ml of fresh medium. Cells were allowed to recover for 
two weeks prior to sampling. 
Hela-Kyoto cells used in this study were cultured in pyruvate-free 
Dulbecco's Modified Eagle Medium (Gibco)  containing 4.5 g/L glucose 
and 1x L-glutamine, supplemented with 10% FBS (PAA), 50 U/ml penicillin 
(Gibco), and 50 μg/ml streptomycin (Gibco) in a humidified 37 degree 
incubator at 5% CO2.  
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2.5 High-throughput RNAi Screening and Automated Image 
Acquisition 
For RNAi screens, cells in serum-free medium were plated into 384-well 
assay plates using a multidrop machine (Thermo Scientific Matrix 
WellMate), centrifuged briefly, and then incubated at 24°C for 15 minutes 
before addition of complete medium. Cells were grown for 5 days at 24ºC. 
In each experiment, positive and negative controls 
(pebble/thread/SCAR/LacZ RNAi) were included. Cells were fixed for 10 
minutes in 4% formaldehyde (Polyscience). After fixation, cells were 
permeabilised by washing with PBS containing 0.1% Triton-X-100 (PBS-T), 
then blocked with 5% BSA in PBS-T for 15 minutes. Cells were incubated 
with primary antibody (α-Tubulin) in PBS containing 1% BSA overnight at 
4°C. Cells were then washed and incubated with secondary antibody 
(FITC anti-mouse IgG) combined with TRITC-Phalloidin and DAPI for two 
hours. After staining, cells were washed and stored in 0.1% Sodium Azide 
in PBS-T at 4°C sealed with Costar6570 Thermowell sealing tape. 
Fluorescent images were acquired using an automated Nikon TE300 
microscope with a 20× objective and HTS MetaMorph software (Universal 
Imaging) running an automated stage, filter wheel and shutter, and a 
cooled-coupled device camera (Hamamatsu). Automated wide focusing 
was performed on the DAPI channel first. Images were acquired in three  
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channels at three sites per well. 
2.6 Two step Reverse transcriptase (RT) Quantitative (Q) 
PCR  
Cytoplasmic RNA was harvested from BG3-c2 and S2R+ cells using the 
RNeasy miniprep kit (Qiagen) according to the
 manufacturer’s guidelines. 
The SuperScript II Reverse Transcriptase kit (Invitrogen) was used to 
synthesise the first-strand cDNA according to the
  manufacturer’s 
guidelines. E. coli RNase H was used to remove RNA complementary to 
the cDNA. Q-PCR was performed using SYBR green (Molecular Probes) 
and an MX4000 real-time PCR machine (Stratagene). SYBR green 
fluorescence was quantified
 using a serial dilution of template containing 
PCR
 products of known concentration. Relative abundance of transcript
 
was normalised against control (rp49) RNA levels.
  Primer sequences 
(Eurogentec) for all genes can be found in additional file 1. 
2.7 Microarray Gene Expression Analysis 
Total mRNA from wild-type cells in exponential growth phase was isolated 
by TRIzol extraction (Invitrogen). Microarray gene expression analysis 
was carried out using FlyChip long oligonucleotide spotted microarrays 
(FL002). Expression data was Loess normalised by intensity and probe 
location per chip, and rank normalised across chips. Normalised  
61
expression was then averaged across three replicate chips for each cell 
line. Hierarchical clustering was performed using the Pearson correlation 
and the average linkage method. All data processing was performed using 
R/Bioconductor by David Sims [95]. 
2.8 Image annotation 
Morphological phenotypes were annotated by eye from the automatically 
acquired images. Phenotypes were described using a controlled 
vocabulary of terms relating to cell shape, size, number and organisation 
of cytoskeleton protein. Each hit was scored for each relevant annotation 
term relative to wild type on a scale from -3 to +3. Phenotypic data was 
recorded using the PHenotype Annotation Tool (PHAT) (http://flight.licr.org) 
[93].  All annotation was carried out blind and repeated at least twice. 
2.9 RNAi and modified RNAi treatment 
RNAi experiments were performed in a range of different tissue culture 
dishes with different starting cell number depending on the assay (Table 2-
2).  
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Plate Size  cell  concentration(cells/ml)  dsRNA(μg) Assay 
4-well 100μl 2×10^6  5.0  IF/WB/Transfection 
6-well 400μl 2×10^6  20.0  WB 
12-well 200μl 2×10^6  6.0 IF/WB 
24-well 100μl 2×10^6  5.0  IF/WB/Transfection 
96-well 40μl 2×10^6  1.5  Microscopy 
384-well 10μl 2×10^6  0.3  Microscopy 
Table 2-2 RNAi treatment in different tissue culture containers for different 
purposes 
Typically, cells suspended in serum-free medium were mixed with dsRNA 
to give a final concentration of 30 ng/μl, centrifuged briefly, and then 
incubated at 24°C for 15 minutes before addition of complete medium. 
Cells were grown for 5 days at 24ºC.  
For modifier RNAi experiments, cells were pre-treated in 0.1 μg/ μl dsRNA 
of gene X in serum free media for 15 minutes before cells were processed 
using a Multidrop 384 liquid dispenser (Thermo Labsystems). 
LacZ (LacZ-f': TAATACGACTCACTATAGGTTGCCGGGAAGCTAGAGTAA; 
LacZ-r':  TAATACGACTCACTATAGGGCCTTCCTGTTTTTGCTCAC) dsRNA 
was used as a negative control in all experiments if not specially 
mentioned otherwise. 
2.10 Molecular biology and Cloning  
2.10.1 Cloning and Sub-cloning Tao-1 (CG14217) from the 
Drosophila cDNA library 
Compared to Human Homologues (PSK1α, PSK1β and PSK2), 
Drosophila Tao-1 (CG14217) has only one isoform which has been  
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confirmed via RNAi and antibodies, although the gene model of Tao-1 
from Flybase (http://flybase.bio.indiana.edu/ ) shows existence of multiple 
transcripts (PA, PB, PD and PE) based on EST data. 
Full length Tao-1 (1039aa) contains a kinase domain, ATPase domain, 
ERM-like domain and three repeated coiled coil regions from the N to C 
terminus (see Figure 2-2). 
Two pairs of primers were used to amplify the full length Tao-1 from the 
cDNA library (from NB’s lab) as the full length Tao-1 is 3120bp, making it 
very hard to generate a PCR product free from mutations in one go.   
Primer pair LT-007 (all cloning primer sequence information can be found 
in the additional file 2) and LT-004(2) were used to PCR Tao-1 from the 
start codon to 1722bp giving fragment 1. Primers LT-005: 5’ and LT-008 
were used to PCR Tao-1 from 1556bp to the stop codon, including the 
mutant stop code and HindIII restriction enzyme site, to form fragment 2. 
Fragments 1 and 2 were cloned into the pGEM®-T Vector Systems 
(promega) as an intermediate step to supply suitable restriction enzyme 
sites. BglII/ApaI and ApaI/EcoRI were used to cut out Fragment 1 and 
Fragment 2 from pGEM-T vectors. Subsequently, the two fragments were 
Figure 2-2 Functional domain distribution in Full length Drosophila Tao-1  
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ligated with pENTR1A simultaneously to create a Gateway® entry vector 
(from Invitrogen life technologies, Catalogue Number 11813011) at 
BamH1 and EcoRI sites. pENTR1A-FL-Tao-1 was sent for sequencing 
after the purification with PureYiedl plasmid midiprep kit from Promega 
(Cat.#A2492) to ensure that no mutations occurred during the cloning and 
subcloning work. There are no mutations in the sequencing results as 
shown in the sequencing results in additional file 3. 
2.10.2 Mutations 
In order to study the function of individual domains of Tao-1, mutations 
based on the entry clone, pENTR1A-FL-Tao, have been made with 
different strategies, as shown in Figure 2-3 below: 
 K56A is a kinase domain point mutation via that is predicted to destroy 
Figure 2-3 Strategy of all mutations made from Full length construct for 
studying the molecular biological function of Tao-1  
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Tao-1’s kinase activity, whilst the other protein domains remain unmodified. 
S180E is a mutant which mimics the T-loop phosphorylated predicted 
‘active’ form of Tao. Δ422-900 is a construct with the ERM-like and 
ATPase domains missing. Δ900-1039 lacks of two repeated coiled coil 
domains which were reported to be related to the microtubule binding 
and/or centrosome localization functions of the protein [96]. Δ51-354 is an 
N-terminal Kinase domain deletion mutation. All these mutations were 
made based on the pENTR1A-FL-Tao so that they could be easily 
recombined into destination vectors with different fusion tags.  
The Quikchange site-directed mutagenesis kit from STRATAGENE 
(Cat.#200519) was used to introduce the point mutations. 
S180E-f’(5’- AAGTGTCCGGCCAACGAATTTGTCGGCACGCCC-3’) and 
S180E-r’(5’- GGGCGTGCCGACAAATTCGTTGGCCGGACACTT-3’) were 
designed as forward and reverse primers for making the S180E construct. 
K56A-f’(5’- GAGATCGTGGCCATCGCAAAGATGTCGTACACC-3’) and 
K56A-r’(5’- GGTGTACGACATCTTCGTGATGGCCACGATCTC-3’) were 
designed as forward and reverse primers for making the K56A kinase 
domain mutant.  
To make Δ 900-1039 and Δ422-900, pENTR1A-FL-Tao was cut open with 
KpnI and HindIII respectively at 1266bp and 3120bp. The strategy is  
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shown in the Figure 2-4. 
  Forward primer NTaoΔ900-1039-f’ (5’- 
ACAGCCGGTACCGCCTGGAGCCGTGTCCCGC-3’) and reverse primer 
TaoΔ900-1039-r’((5’-CGAAGCTTCTATTTGTAGCTCTGACTTTGGAAC-3’) 
were used to obtain the PCR segment which is approximately 1.4kbp from 
1260bp to 2700bp with incorporated KpnI and HindIII.  Forward primer-
NTaoΔ422-900-f’:  
(5’-GCGGTACC ACTAGACGAAAGCCAAGTGATTGAGTGC-3’) 
containing a KpnI site and reverse primer-TaoΔ546-900-r’:  
(5’- CG AAGCTTCTATAGCGAACCAGCCGGAAAACTTG-3’) with a HindIII 
site were used to perform the PCR to obtain the segment which is about 
420bp to get the pMT-GFP-TaoΔ422-900 mutation. PCR segments then 
were subcloned into a pGEM-T vector (from Promega), cut with KpnI and 
HindIII to generate the sticky ends for re-insertion into the linearized 
pENTR1A-FL-Tao-1 vector.  
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After ligation, final constructs were sequenced and confirmed that no 
mutations were introduced during the PCR process (sequence results are 
in additional file 3). 
To make Δ51-354, pENTR1-FL-Tao was cut open with XcmI which cuts 
full-length Tao twice at 153bp and at 1062bp respectively, and the 
remaining part, which is still inframe, was then ligated to generate the 
construct pENTR1A- Δ51-354.  
PCR was carried out as follows:  
1) 1.25  μl  primer pair (5 μmol) 
2) 1.25  μl  dNTP (2.5 mM) 
3) 0.2  μl  HotstarTaq DNA polymerase (from Qiagen, 
Cat.#203205) 
4) 3  μl  10xBuffer 
5)  100 ng pMT-GFP-Tao-1 
6) 24  μl  dH2O 
Figure 2-4 The cloning strategy for Δ900-1039 and Δ422-900 mutations  
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With a program: 
1)  95 ºC  15min 
2)  94 ºC  30sec 
3)  55 ºC  30sec 
4)  72 ºC  1min 
5)  go to step2 for 24 cycles 
6)  72 ºC  10min 
7)  4 ºC   hold 
Samples were sent for sequencing after the purification with PureYield 
plasmid midiprep kit from Promega (Cat.#A2492). All sequence results 
showed that the expected residues were mutated, while other parts of the 
constructs were unaffected (sequence maps as shown in additional file 3). 
2.10.3 Drosophila Gateway recombination cloning system 
A universal cloning method named Gateway Technology based on the 
site-specific recombination properties of bacteriophage [97] has become 
more and more popular as a way of simplifying cloning work in life 
sciences. Gateway Technology provides a rapid and highly efficient way to 
move DNA sequences into multiple vector systems for functional analysis 
and protein expression (see Figure 2-5).  
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This technology enabled me to efficiently move various DNA sequences 
into different constructs for different purposes, such as protein expression 
and functional analysis, without considering changing the orientation and 
open reading frame. 
Different destination vectors were used to generate constructs with 
different promoters and fusion tags. The details were as shown in the 
Table 2-3: 
 
 
Figure 2-5 Gateway Technology-easy strategy to cloning a gene using 
different expressed destination vector. (Modified from Invitrogen website) 
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  Construct Name  Promoter  Fusion tag  Antibiotic 
Resistance 
P-element
1 pMT-GFP-FL-Tao  pMT  N-terminal  GFP  Amp  no 
2 pMT-RFP-FL-Tao  pMT  N-terminal  GFP  Amp  no 
3 pMT-GFP-S180E  pMT  N-terminal  GFP  Amp  no 
4 pMT-GFP-K56A  pMT  N-terminal  GFP  Amp  no 
5 pARW-K56A  Actin5c N-terminal  RFP  Amp  no 
6 pARW-delta-900-
1039 
Actin5c N-terminal  RFP  Amp  no 
7 pARW-delta-422-
900 
Actin5c N-terminal  RFP  Amp  no 
8 pARW-delta-51-
354 
Actin5c N-terminal  RFP  Amp  no 
9 pPGW-FL-Tao  UASp  N-terminal  GFP  Amp  yes 
10 pPGW-K56A  UASp N-terminal  GFP  Amp  yes 
11 pPGW-delta-422-
900 
UASp N-terminal  GFP  Amp  yes 
Table 2-3 All the constructs, fusion tags and promoters used in this study 
pARW, pPGW (Invitrogen) and N-terminal pMT-GFP/RFP-ccdB (a gift 
from Dr. Jeroen Dobbeleare in Jordan Raff’s lab) is a modified gateway 
destination vector that was used for the LR reaction with pENTR1A-Tao-1 
to create a Gateway® expression clone. The protocol of the LR reaction is 
as follows: 
1)  Entry vector pENTR1A-Tao-1 (150 ng/µl) 1.5 µl 
2)  Destination vector  pMT-GFP/RFP-ccd (150 ng/µl) 
1.5 µl 
3)  LR Clonase™ II enzyme mix 4.0 µl 
4)  10x buffer 2.0 µl 
5) Add  dH2O to 20 µl reaction 
This was mixed well by vortexing briefly and incubated at 25°C for 4 hours. 
Next, 100μl Dh5α was transformed with 5μl of the mixture according the 
protocol from the kit (Invitrogen gateway vector system). Purification of the 
pMT-GFP-Tao-1 was carried out using the PureYield plasmid midiprep kit 
from Promega (Cat.#A2492).   
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2.11 Transfection 
Drosophila S2R+ and S2 cells were transiently transfected using 
FugeneHD (Roche, Lot#93539521) transfection reagent. 1.0 μg plasmid 
was mixed with 3 μl of FugeneHD reagent in 50 μl of serum-free M3 
medium and incubated at room temperature for 60 minutes. Meanwhile, 
5x10
5 S2R+ cells previously plated into a 4-well dish were washed twice in 
300μl of serum-free medium. Next, the plasmid and FugeneHD mixture 
was added to the cells, with an additional 300μl complete media, resulting 
in a total volume of 700 μl in each well. Cells were incubated for 12 hours 
at 24°C before changing the media. After 24-48 hours, cells were moved 
to FCS coated glass bottom coverslips. Where necessary, gene 
expression was induced the following day by addition of CuSO4 solution 
(the final concentration of Cu
++ is 70 nm). 
2.12 Cell number measurement   
Cell number counts were used to gain a quantitative assessment of the 
Mnb phenotype in S2, BG2, BG3-C1 and BG3-C2 cells. In each case, 
1.5x10
6 cells were treated with Mnb or LacZ dsRNA in 4 well-dish. On the 
5th day, cells were counted in triplicate using a Beckman Z2 Coulter 
Counter. The average cell number and standard deviation are presented 
for each.  
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2.13 Antibody and Western Blotting 
We made rat multipeptide-antibody against Tao-1 both on the C-terminal 
part: 967-981: C+FNQERAERLRMKHEK-CONH2 and the N-terminal part: 
2-16: CONH2-PSARPGSLKDPEIAD+C. The rabbit multipeptide-antibody 
against P-Tao-1 was made based on sequence CONH2-
RAQRATS[P]NVFAMC+3, which has been confirmed as the T-loop 
phosphorylation site [98]. All of these antibodies were ordered from 
Eurogentec. 
Samples were lysed in 2 x laemmli buffer and boiled at 95°C for one 
minute before loading. Samples were run on a 4-12% graduated SDS-
PAGE gel (Invitrogen), and then transferred to nitrocellulose blotting paper 
(Invitrogen). Membranes were blocked with 5% skimmed milk in TBS-T for 
30 minutes, incubated overnight at 4°C with appropriate primary 
antibodies (1:1000 for P-Tao antibody and 1:500 for non-ph-Tao antibody), 
and then washed three times with TBS-T for 15 minutes each time. 
Membranes were then incubated with appropriate horseradish peroxidase 
(HRP) conjugated secondary antibodies (1:2000) in TBS-T for one hour, 
and washed as before. The Super Signal West Pico Chemiluminescent 
Substrate (PIERCE) was used for detection. After incubation with the 
reagent, the membrane was wrapped in SaranWrap and exposed to 
Hyperfilm EC (Amersham Biosciences) under dark-room conditions. The  
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resulting films were scanned and quantified with metamorph6.2 and 
photoshop7.0 software. 
2.14 Tissue staining 
I used w118;UASp-GFP-Tao in crosses with different Gal4 drivers to 
generate homozygous flies in which to observe GFP-Tao’s localization in 
fly egg chambers. Flies were fed yeast for 2 days before the isolation of 
ovaries. For egg chamber analysis, 5 well-fed females of each genotype 
were dissected to obtain about 10 ovaries in total. For antibody, TRITC–
phalloidin and DAPI staining, tissue was fixed in 4% formaldehyde in PBS 
for 20 min. Tissue was then pre-washed in 1% Triton X-100 for 4 h at room 
temperature, blocked in 5% BSA, 0.1% Triton X-100 (PBT) and incubated 
overnight at 4°C in TRITC–phalloidin (Molecular Probes) and DAPI (1 
μg/ml), before mounting in antifade and glycerol. 
2.15 Microscopy 
2.15.1 Automated stage microscope 
A Nikon TE2000E Inverted Microscope with an automated stage was used 
for capturing data from screen experiments. The TE2000-E has a high 
precision Z-axis automated focus (with a linearly encoded Z-axis minimum 
step size of of 0.05 microns), allowing us to take pictures for each well in a 
wide region in the 384-well plate without losing focus.   
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2.15.2 Confocal microscopy and Fluorescence time-lapse live 
imaging acquisition 
For immunostaining, S2 and or S2R+ cells were fixed with either –20°C 
methanol or 4% formaldehyde. Antibodies used in this study were 
diluted to concentrations ranging from 1 to 20 µg/ml (anti-Tao-1 and anti-
P-Tao-1 [our lab], anti-Cnn [J. Raff, University of Cambridge], DM1a  -
  tubulin [Sigma], phosphohistone H3 [Upstate Biotechnology], anti-GFP 
[LabVision, Fremont, CA; #MS-1315-PO]. Secondary  antibodies (FITC, 
TRITC,Cy5 and TRITC; Jackson ImmunoResearch, WestGrove, PA) were 
used at final dilutions of 1:1000 [99]. Cells were mounted in a 0.1 M propyl 
galate-glycerol solution. DAPI (Sigma) was used at a concentration of 5 
µg/ml.  
For cold-shock experiments,  S2R+ cells pre-spread on Concanavalin A 
(ConA) coated 35 mm optical quality glass-bottomed culture dishes 
(MatTek Corporation, USA) were placed  on a partially submerged 
aluminum block in a water-ice bath at 0°C for 2.5 hours in the 4°C cold 
room environment and allowed to recover at room temperature. 
Compared with other microscopy systems, the confocal laser scanning 
microscope has several advantages, the most important being its high 
spatial resolution in z compared with non-confocal light microscopy. In this 
study, a Leica TCS SP5 with a HCxPL 40x/1.25 oil-immersion lens (Leica)  
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and a Leica DFC400 camera was used for high resolution cell imaging in 
vivo and in vitro. The software platform used was LAS AF. An inverted 
confocal system, Leica TCS SP5 was used to perform all the time-lapse 
imaging work. 
For time-lapse microscopy imaging, cells were plated onto ConA (50 µg/ml) 
coated 35 mm optical quality glass-bottomed culture dishes (MatTek 
Corporation, USA). Phase-contrast and fluorescence time-lapse movies 
were taken on the Leica TCS SP5 with a Leica DFC295 digital camera, 
using a HCxPL 40x/1.25 oil-immersion lens at 2 seconds intervals. 
Microtubule dynamics were analysed in live RNAi-treated or transfected 
cells by time-lapse fluorescence microscopy using GFP or RFP fusion 
protein. 0.5  μM Latrunculin B (LatB) which sequesters G-actin and 
promotes actin depolymerization was used for drug treatment experiments.  
2.15.3 TIRF microcopy  
The Leica multicolor TIRF (Total Internal Reflection Fluorescence) all-in-
one system was used in this study to demonstate Tao-1’s membrane 
localization. It has four integrated solid state lasers for excitation of 
fluorophores in wavelengths 405 nm, 488 nm, 561 nm and 635 nm. The 
extremely short switching times and constant TIRF penetration depth of 
90nm enabled us to study the processes of microtubule plus end 
dynamics at cell cortex and the interaction between our protein of interest,  
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Tao-1 and +TIPs in living cells.   
1x10
6 RNAi treated or transfed cells were plated onto ConA (50 µg/ml) 
coated 35mm optical quality glass-bottomed culture dishes (MatTek 
Corporation, USA), and left to attach to the bottom and spread completely 
for 30 minutes prior to loading onto the TIRF microscope with HCX PL 
APO 63x/1.40 oil-immersion lens (Leica). Florescent images of both GFP 
and RFP were acquired every 2 seconds. 
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Chapter 3 
Results: Parallel RNAi screens across 
different cell lines to identify kinases that 
regulate cell morphology 
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3.1 Introduction 
In recent years RNAi screening has proven itself to be a powerful tool for 
dissecting gene function. To date, most RNAi screens have been 
performed in a single cell line. Results have then been extrapolated to all 
cell types and other systems. This is the case even though multi-cellular 
organisms are composed of a large variety of specialised cell types with 
distinct morphologies and functions.  
A diversity of cell shapes is a fundamental feature of multicellular life. Cell 
type specific forms arise during development as the products of a cell 
differentiation program that refines patterns of gene expression to yield 
cells with a form and behaviour appropriate to their function. To establish 
how the forms that characterise cells from different lineages are generated, 
we have used Drosophila cell lines derived from distinct tissues as a 
model system.  
Drosophila cells lines provide a good model for such an analysis, since 
multiple cell lines have been derived from diverse tissues, including 
haemocytes [100-102], neuronal tissue [103] and imaginal discs [104, 105], 
and because all these cell lines have morphologies that appear consistent 
with their lineage. Thus, S2 and S2R+ cells have broad lamelliopodia and 
are similar in both form and behaviour to larval blood cells [105] (Sims et 
al., unpublished data), while BG1, BG2 and BG3 nervous system-derived  
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cell lines have a common morphology and cyto-architecture [105], which 
includes filopodia embedded in lamellipodia [84], reminiscent of those 
seen in neuronal growth cones [106]. It has long been hypothesised that 
the morphological diversity of different cells types is decided largely by 
differential gene expression and consequently differential regulation of 
signalling pathways and cytoskeletal genes [107]. However, the genes 
required to establish these different forms remain largely unknown. I used 
gene expression microarray gene expression analysis together with RNAi 
screening in a panel of Drosophila cell lines to identify cell type-specific 
cytoskeletal regulators, and to explore the relationship between gene 
expression and function across a panel of cell lines. Since the structural 
components of the cytoskeleton and their core regulators (e.g. cofilin and 
profilin) are likely to function in a broadly similar way across cell types, I 
focused our analysis on the kinome to identify cell type specific differences 
in the regulation of this basic cytoskeletal machinery. Kinases are a well-
defined family of proteins characterised by a common catalytic domain 
that regulate myriad cellular processes, including the organization of the 
cytoskeleton, and hence cell shape [108-110]. They can be divided into a 
number of sub-families based on the structure of the kinase domain in 
each case [92]  
 In doing so, I identified a set of common regulators of cell behaviour and  
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morphology, together with a group of cell-type specific kinases. Importantly, 
this analysis also revealed that, when considering the kinome, gene 
expression signatures are a poor measure of cell type specific differences 
in gene function. 
3.2 Cell Lines from the Same Origin Display Similar 
Morphologies and Gene Expression Patterns 
We chose to use six different cell lines from two different tissues of origins 
in RNAi screens for novel genes involved in the generation of cell form. In 
Drosophila, S2, Kc167 and S2R+ cells, which originate from embryonic 
haemocytes [100-102], are relatively symmetrical in shape and are non-
motile as shown in (see Figure 3-1). 
 
 
Figure3-1 The three CNS-derived cell lines BG2-c2, BG3-c1 and BG3-
c2 have a bipolar, spiky cell shape, whereas the three embryonic 
haemocyte derived cell lines S2, S2R+ and Kc167 have a symmetrical 
morphology. Gene expression profiles for each cell line were 
normalised and hierarchical clustering was used to generate the 
dendrogram shown. This analysis reveals that cell lines from the same 
origin have closely related gene expression profiles. (scale bars 
represent 10 µM in each picture.)  
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Note that the S2R+ line is an original isolate of the S2 line [102]. In 
addition, these haemocyte lines have a propensity to develop lamellipodia 
rather than filopodia [89]. By contrast, BG2-c2, BG3-c1 and BG3-c2 cells 
originate from neuronal tissue [103], are migratory (Wei-Bai, Baum and 
Ridley, unpublished), and have a polarised shape characterised by long 
actin-rich protrusions embedded in lamellipodia [84]. Note that BG3-c1 
and BG3-c2 represent different clonal isolates from a single primary 
culture [103].  
To determine whether the common origins of these six cell lines are 
reflected in their respective gene expression profiles, I compared the 
microarray gene expression analysis data available in our lab which were 
done by David Sims on each of the six lines (see materials and methods). 
By clustering these results, it was clear that cell lines from the same tissue 
of origin have related patterns of gene expression (see Figure 3-1), 
leading us to conclude that these cell lines are suitable in vitro models in 
which to study the regulatory networks underlying these two distinct cell-
type specific morphologies.  
3.3 Parallel High-throughput RNAi screen identified a key 
set of kinases in charge of regulating cell morphology 
I designed and constructed a dsRNA library targeting 265 Drosophila 
kinases and kinase regulatory subunits (list in additional file 4), which  
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could be screened in 384-well plates using the bathing method [111]. For 
the screen, cells were added to library plates and incubated for five days 
to allow for the turnover of existing proteins. Cells were then fixed and 
stained to visualise actin filaments, microtubules and DNA, and images 
were acquired using automated microscopy (see methods and materials). 
Each cell line was screened independently at least twice. All cell images 
and hit annotations are available online through the online FLIGHT 
database (http://flight.licr.org/) [93].  
Of the kinases screened, 17.7% (47/265) yielded a visible phenotype in at 
least one of six cell lines as shown in additional file 5. The hit rate however 
varied considerably across lines (see Figure 3-2). 
 
 
Figure 3-2 Different cell lines exhibit different hit rates in RNAi 
screens  
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Based on the results of the positive control Thread RNAi, which led to cell 
death in all experiments with each cell line, it appears that this variability 
was not due to differences in the efficacy of RNAi. Instead, the differences 
appear to be due to variation in the ease of identifying defects in cell 
morphology in each case. Thus, all the hits identified in the BG3-c1 cell 
line, which is prone to grow in clumps, were identified in at least one of the 
more easily visualised CNS lines (see Figure 3-3).  
 
Similarly, only one gene was identified that yielded a phenotype in S2 or 
Kc167 cells but did not also show up as a hit in the larger, more well-
spread S2R+ cell line (Figure 3-4).  
Figure 3-3 Venn diagrams depict the segregation of screen hits between 
CNS original cell lines  
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In contrast, there were significant differences in the kinase requirements of 
haemocyte and CNS-derived lines (Figure 3-5) that correlate well with the 
differences in the form and gene expression profiles that separate these 
two sets of lines (see Figure 3-1).  
Figure 3-4 Venn diagrams depicting the segregation of screen hits 
between CNS original cell lines  
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This indicates that both gene expression and function can be used as 
indicators of a common origin. It was then possible to identify a set of ‘cell 
Figure 3-5 A Venn diagram 
depicting the classification of hits 
into three distinct classes: those 
which are hits in both CNS and 
haemocyte cell lines, those 
which are hits in neuronal cell 
lines only and those which are 
hits in haemocyte cell lines only. 
 
Figure 3-6 Hierarchical clustering of hits across cell lines (depicted in 
the form of a tree) was used to give a more detailed picture of the 
three hit classes. Two hits of particular interest; CG7236, Mnb and Pvr 
are highlighted.  Note that the relationships defined by the functional 
analysis mirror the relationships defined by the microarray analysis  
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type specific’ hits and a group of uniform hit across all cell types (Figure 3-
6). However, there was no detectable bias in the number of hits in each 
kinase class between the two different tissues of origin (Table 3-1). 
   Total Neuronal % Haemocyte % 
Serine/threonine kinase 146 21 14.4% 22 15.1%
Tyrosine kinase  49 5 10.2% 6 12.2%
Protein kinase  26 3 11.5% 2 7.7%
Lipid kinase  23 3 13.0% 2 8.7%
Guanylate kinase  7 0 0.0% 1 14.3%
Protein kinase-like  5 0 0.0% 0 0.0%
Others  5 2 40.0% 1 20.0%
Table 3-1 Breakdown of RNAi screen hits according to kinase families 
As shown in Figure 3-7, a pie chart summarizes the gene expression 
profiles (present or absent) of genes showing phenotypes in any cell line. 
The vast majority of genes with expression data available is either present 
in all cell lines tested, or absent from all. This suggests that cell type 
specific phenotypes do not arise simply from expression of different 
subsets of signaling components.  
87
 
Using phenotypic clustering to identify genes affecting cell morphology 
across all six cell lines allows us to identify three strong kinase clusters 
(Figure 3-6). The first cluster (C1) contains genes which have a strong 
phenotype in almost all cell lines tested. This cluster appears to be 
enriched in genes which participate in basic cell biological processes such 
as cell cycle control (e.g. cdc2, polo and ial). The second cluster (C2) 
contains genes that are hits in cell lines of haemocyte origin. The final 
cluster (C3) contains genes which are hits only in CNS-derived cell lines. 
In the subsequent analysis, I focused on genes with functions specific to 
one tissue type of origin 
3.4 False positive analysis using multiple oligos 
Although Dicer-mediated processing of long dsRNAs to generate a 
Figure 3-7 Summary of the gene expression of all genes with 
phenotypes across all cell lines  
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diverse population of siRNAs inside Drosophila cells is thought to reduce 
the probability of off-target effects [87], false positives are always an 
important issue in high-throughput RNAi screening [112].  In this study, I 
systematically analysed the false positive rate using multiple oligos. As 
shown in Figure 3-8, I used a set of genes covered by both library A and B 
which has different oligos targeted to different part of the genes to do the 
analysis in 2 cell lines S2R+ and BG2.  
 
A gene should only be considered a positive if it has been identified as a 
Figure 3-8 Using multiple oligos to avoid false positives and estimate 
the false positives rate 
Third oligos have been used for genes which show different results in 
both libraries A and B in S2R+ and BG2 cell lines  
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hit in two independent experiments using dsRNAs targetting different 
regions of the same mRNA. Therefore, for those genes that were a hit with 
only one of the two RNAi libraries (A or B), I designed a 3
rd pair of oligos. 
The idea was to use this 3rd pair of oligos to confirm which of these were 
true hits. In this way, I hoped to find out whether these represent false 
positives or false negatives and to estimate the false positive rate.  The 
results from three RNAi experiments are shown in additional file 6. For 
S2R+ cells, 2 false positives were identified from a total of 16 hits from 
library A, and two out of 18 hits as false positives in library B. For the BG2 
cell line, 1 false positive was identified from a total of 15 hits from both 
libraries. Based on these data I estimate the false positive rate in our 
experiment as between 6.7-12.5%.  
3.5 Parallel RNAi Screens Reveal Cell-type Specific 
Phenotypes-CG7236 Displays a Haemocyte-specific 
Phenotype 
The C2 cluster contains genes that were only identified as hits in 
haemocyte cell lines. One such gene is a Cyclin-dependent kinase (CDK) 
called CG7236 [113]. CDKs are known to regulate cell cycle dependent 
changes in cell organisation together with a host of other processes, such 
as RNA Polymerase II activity [114]. In haemocyte cell lines RNAi-
mediated silencing of CG7236 led to the accumulation of large cells with  
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multiple or enlarged nuclei (Figure 3-9). I quantified the number of 
multinuclear cells in CG7236 RNAi treated S2R+ cell to confirm that this 
result is statistically significant.  
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Figure 3-9 CG7236 loss of function shows cell line specific phenotypes 
Silencing of the Cdc2-related kinase CG7236 in S2R+ cells gives rise 
to large cells that frequently contain multiple nuclei or a single large 
nucleus, whereas silencing in BG3-c2 cells has no discernable 
phenotype. Note: bottom panel shows confocal images of RNAi 
treated S2R+ cells and BG3-C2 cells. 
Figure 3-10 Quantification of the 
CG7236 loss of function 
phenotype in SR+ cells indicates 
that the percentage of 
multinucleate cells in CG7236 
RNAi treated cells is much 
higher than it is in the control.  
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The phenotype was verified using independent dsRNAs and confocal 
imaging (Figure 3-9, bottom panels), and suggests a role for CG7236 in 
the regulation of the cell division cycle. However, silencing of CG7236 
caused no detectable change in the appearance of neuronal cell lines 
such as BG3-c2 (Figure 3-9), even though a Q-PCR analysis revealed that 
CG7236 is both expressed and effectively silenced by RNAi in both S2R+ 
and BG3-c2 cells (Figure 3-11).  
 
CG7236 has not been studied in detail before, but was previously 
identified as a cell cycle kinase in an RNAi screen in S2 cell [115], and as 
having a cytokinesis defect in RNAi screens in Drosophila haemocyte cell 
line [116, 117]. By analysing its function across cell-types, our analysis 
suggests that CG7236 differs from many other kinases involved in cell 
Figure 3-11 Q-PCR analysis revealed that CG7236 is both expressed 
and effectively silenced by RNAI treatment in both S2R+ and BG3-C2 
cells  
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cycle control in performing a cell type-specific function. Using a Q-PCR 
analysis revealed that CG7236 was expressed and effectively silenced by 
RNAi in both S2R+ and BG3-c2 cells. 
3.6 Genes with Cell-type Specific Phenotypes are not 
Differentially Expressed 
In order to test whether these phenotypic differences reflect differences in 
gene expression between different cell lineages I used the gene 
expression data available in our lab (it is open access in FLIGHT website. 
http://flight.licr.org/search/expression) to determine whether the 
differences in gene expression correlate with differences in function, as 
ascertained using RNAi across the kinome (see Figure 3-12). 
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I was unable to identify a correlation between gene function and 
expression. However, given the potential problems with a global 
microarray analysis, I followed this up using Q-PCR to establish whether 
the relative levels CG7236 expression in S2R+ and BG3-c2 cells correlate 
with their cell type specific functions. Pvr, a gene that displayed similar 
strong phenotypes in all cell types screened (see Figure 3-6) was used as 
a control for this analysis.  
Figure 3-12 Comparison of microarray gene expression levels of 
genes displaying phenotypes in S2R+ and BG3-c2 cells 
Chart of the gene expression levels determined in the microarray 
analysis for genes showing phenotypes in both S2R+ and BG3-c2 
cells compared to those with phenotypes in BG3-c2 or S2R+ cells. 
There is no strong pattern of gene expression associated with genes 
with cell-type specific phenotypes.   
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The result shows no clear correlations between expression at the mRNA 
level and function (Figure 3-13). Thus, CG7236 mRNA levels are similar in 
BG3-C2 cells and in S2R+ cells, despite its only having a phenotype in the 
S2R+ cells (Figure 3-13). Furthermore, Pvr, which displayed strong 
phenotypes in both S2R+ and BG3-c2 cells, was expressed at very 
different levels in the different cell lines. These data suggest that there is 
little relationship between gene expression level and function – at least for 
kinases.  
3.7 Conclusions 
In this chapter presents the results from parallel RNAi screens across 
multiple Drosophila cell lines. It is not surprising to see that cells derived 
from the same tissue appear similar in their morphology and gene 
Figure 3-13 Genes with cell line specific phenotypes are not 
differentially expressed  
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expression patterns by comparison of my screening data and gene 
expression data available in our lab. However, more interestingly my 
results prove that different type cells have their own cell type specific gene 
functions. This means the screening result from one cell line can not be 
extrapolated to all the other cell types and other systems. Importantly, I 
estimated the false positive rate in my high-throughput RNAi as between 
6.7-12.5%. This result suggests that false positives are likely to be a 
problem in high-throughput RNAi screens in fly cells. It may therefore be 
better to minimize the false positive rate by using multiple non-overlapping 
dsRNA libraries for screens.  
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Chapter 4 
Identification of Minibrain/DYRK1A as a 
cell-type specific regulator of actin 
organization 
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4.1 Introduction- Drosophila Mnb and its human orthologue 
DRYK1A 
In this parallel RNAi screening analysis, I identified a set of kinases which 
have functional phenotypes in neuronal cells but not in haemocytes as C3 
cluster (see Figure3-6). One of these cell type specific kinases is minibrain 
(mnb). It belongs to the Serine/Threonine kinase subgroup [118]. Mnb was 
firstly identified by Tejedor et al in 1995 as a regulator of postembryonic 
neurogenesis in Drosophila, since mnb mutant adult flies exhibit a specific 
and marked size reduction of the optic lobes and central brain 
hemispheres[119].  More recently, DYRK1A, a human orthologue of mnb, 
was mapped within the Down's Syndrome (DS) critical region of 
chromosome 21 and found to be over-expressed in DS embryonic brains 
[120]. An analysis of the distribution of DYRK1A in primary cell culture 
showed the presence of this protein in the nucleus and the cytoplasm of 
both neurons and astrocytes [121]. Moreover, studies on the biochemical 
function of DYRK1A show that Mnb/DYRK1A can phospohorylate 
Dynamin1 to alter its interactions with several SH3 domain-containing 
endocytic accessory proteins [118], which hints at a function for mnb in the 
regulation of the actin cortex. Recent published data identified Bmh1/2p, 
the yeast homologue of protein 14-3-3, as a regulator of Yak1p the S. 
cereviaise orthologue of DYRK1A [122]. The data in human cells show  
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that a small peptide inhibiting 14-3-3 binding, sc138, decreased DYRK1A 
kinase activity, implicating 14-3-3 in the regulation of DYRK1A activity [123, 
124]. However, so far, there is no report about Mnb’s function in the 
regulation of cell morphology.  
4.2 Mnb has a specific role in the regulation of neuronal 
cell morphology and modulates Actin-based Protrusions in 
CNS-derived Cell Lines 
I identified Minibrain (Mnb) as a kinase that has strong morphological 
RNAi phenotypes in all neuronal cell lines tested, without eliciting a visible 
RNAi phenotype in haemocyte cell lines. As before, the specificity of the 
RNAi phenotype was confirmed using two sequence independent dsRNAs 
in BG3-c2 cells to minimise the chances of sequence-specific off-target 
effects [88]. In all neuronal cell lines tested, Mnb RNAi treated cells had a 
spiky cell shape caused by the formation of extra actin based protrusions 
(phenotypes shown as Figure 4-2). The Mnb loss function phenotype was 
similar across all the 3 neuronal cell lines tested, leading to a significant 
>2-fold increase in the number of long finger-like protrusions around the 
cell body (Figure 4-3), an increase in cortical F-actin levels (see Figure 4-
2), and reduced cell numbers (see Figure 4-1). Cell number of each 
condition was quantified using a Beckman Z2 Coulter Counter (see 
materials and methods 2.11). By contrast, S2R+ cells had no detectable  
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phenotype and kept their flat cell shape and smooth edges. Interestingly, 
RNAi mediated silencing of Drosophila Smi35A (the closest human 
homologue of this gene is DYRK4) a close homologue of Mnb (there are 
only 2 isoforms in Drosophila) had no visible actin phenotype, while a 
knock-down of Smi35A enhanced the Mnb finger-like actin protrusion 
phenotype by 30% compared to a LacZ dsRNA control. This may suggest 
thatthese two isoforms have functional redundancy in Drosophila. DYRK4 
has been reported to function as a testis-specific kinase with a very 
restricted expression to stage VIII postmeiotic spermatids in mice [125]. 
The reduction in cell number following mnb silencing in CNS-cell lines 
could be due to the activation of apoptosis rather than inhibition of cell 
proliferation, as a recent study demonstrated that Mnb/DYRK1A 
phosphorylates caspase-9 on threonine residue 125, a phosphorylation 
event that is crucial for protecting cells from apoptotic cell death [126].  
  Figure 4-1 Mnb silencing cells reduce their cell number   
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Figure 4-2 Mnb has cell type specific phenotype only in neuronal cell 
lines (serum coated substrate)  
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Significantly, filopodia are absent from the blood cell lines, but are seen in 
all CNS-derived Drosophila cell lines tested [127]. Moreover, these actin 
structures are superficially similar to actin-based protrusive structures 
seen embedded in the growth cones of migrating neurons [128, 129], 
where such finger-like processes are thought to sense local cues to guide 
the migrating neuron to its target [130], whilst the large mesh-like 
lamellipodium in which they are embedded generates the forces required 
to drive the growth cone or cell forwards [131-133]. Given this role for mnb 
in shaping actin-based protrusions, I considered two explanations for its 
neuronal-specific RNAi phenotype. First, it is possible that the dsRNA 
failed to silence the mnb expression in haemocyte cell lines or that mnb is 
not expressed in haemocyte-derived cells. However, a Q-PCR analysis 
Figure 4-3 Quantification of filopodia around bipolar cell body shows 
significant incense in Mnb-silenced cells  
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revealed that Mnb effectively silenced by RNAi in both S2R+ and BG3-c2 
cells (see Figure 4-4 a) and that mnb was expressed in both cell lines (see 
Figure 4-4 b), ruling out this explanation.  
 
Second, I considered the possibility that the ability to visualise a 
morphological phenotype associated with the loss of mnb was dependent 
on the shape of the cells used in the analysis. To test whether this, I forced 
BG3-c2 cells to spread on a Conconavalin A coated substrate (see Figure 
4-5).  
Figure 4-4 Q-PCR can 
rule out the possibility 
that mnb is not silenced 
or not expressed in 
S2R+ cells. 
b 
 
 
a  
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Although this led to the formation of broad lamellipodia in control (lacZ 
RNAi treated) BG3-c2 cells, it was unable to suppress the induction of 
ectopic filopodia induced by Mnb depletion. Thus, I cannot attribute the 
failure of mnb dsRNA to elicit an RNAi phenotype in Kc, S2 and S2R+ 
cells to differences in their form. Instead, these results suggest that mnb 
specifically acts to inhibit the transition between filopodia and lamellipodia 
in CNS-derived cells. Since mnb plays a conserved role in neurogenesis, 
and has a strong cell morphological RNAi phenotype in CNS-derived cell 
lines, it seems likely that its represents a cell type specific regulator of cell 
morphology and behaviour.  
BG3-c2 cells originate from neuronal tissue [103], are migratory (Wei-Bai, 
Baum and Ridley, unpublished), and have a polarised shape characterised 
by long actin-rich protrusions embedded in lamellipodia and filopodia [84]. 
Figure 4-5 Forcing BG3-C2 cell spread on ConA substrate to form broad 
lamellipodia can not inhibit mnb depletion phenotype.   
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The first step for a cell to migrate is to re-organise its actin filaments and 
generate a leading edge in response to extracellular or cellular signals [16]. 
Actin assembly drives the extension of flat membrane protrusions-
lamellipodia and finger-like protrusions-filopodia. Thus, using BG3-C2 
cells in culture enables us to study the role that mnb plays in the dynamic 
regulation of actin based finger-like protrusions. I found that by silencing 
mnb in BG3-C2 cells not only can many finger-like protrusions be 
generated in a short time scale but also that they are very dynamic 
structures as shown in the Figure 4-6. The kymograph shows that the cell 
edge in Mnb RNAi cells is much more dynamic than that of control cells. In 
addition, BG3-C2 cells lose their big lamellipodia at a time when they 
generate more finger-like protrusions, implying that Mnb may induce a 
switch in actin structure. It has been reported that the function of N-WASP 
in cell migration is restricted to filopodia formation in response to Cdc42 
[134], whereas WAVE/Scar is responsible for lamellipodium protrusion in 
response to Rac1 [10]. It remains to be tested whether Mnb acts by 
promoting the formation of lamellipodial actin or by inhibiting filopodial 
actin formation, e.g. via Cdc42-WASP-Arp2/3 or Formins.     
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4.3 Conclusions 
In this chapter, I characterized the function of a second cell type specific 
kinase (in addition to CG7236). Mnb RNAi only induces strong actin-based 
cell morphological phenotypes in CNS-derived cells. Importantly, I showed 
that the differences between the effects of Mnb RNAi on S2R+ and BG3-
c2 cells are not due to different gene expression levels in these 2 cell 
types by measuring mRNA levels. This result strengthens the idea that it is 
important to use different cell types to gain a thorough understanding of 
gene function across the genome, and the difficulties of using gene 
expression to predict gene function. Although I didn’t have the chance to 
follow up the work on Mnb to explore whether Mnb is directly involved in 
the regulation of actin dynamics , my analysis gives a clue that helps to 
explain the findings in Mnb null mutant flies which lead to viable, externally 
normal animals that display strong behavioural defects and a reduction in 
brain mass [119].   
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Chapter 5 Results: 
The Identification of the Tao-1 Kinase as 
a Key Regulator of Microtubule Dynamics 
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5.1 Introduction 
The Tao-1 kinase was first identified as a MAPKK isolated from a rat cDNA 
library  in 1998 [135]. Since then, several different functions have been 
attributed to this STE20 kinase family member in different species: in the 
regulation of the cytoskeleton, apoptosis, in c-Jun N-terminal kinase, p38 
mitogen-activated pathway and spindle-checkpoint signaling [96, 136-141].  
The kinase derives its name from its Thousand-And-One amino acids in 
rat and is highly conserved across animals. Its C. elegans homologue 
named KIN-18 has been reported to be able to reduce worm feeding, 
which results in slow growing and fewer eggs laying in an expressing 
active form [142]. In S. cerevisiae, USO1 could be considered a Tao-1 
homologue, but has only 56% similarity with Drosophila Tao-1. It is been 
thought to function as a vesicle docking protein [143].  Drosophila Tao-1 
has 90% amino acid sequence similarity with its human homologues, 
PSK1 and PSK2, which were identified as MAPKKs in human prostatic 
carcinoma cells [96]. The earliest report of the Tao-1 kinase being 
functionally related to the cytoskeleton comes from Jonathan Morris’s lab 
[96]. They cloned PSK from a T-47D breast carcinoma cell line using 
reverse transcription [96]. The p21-activated protein kinases (PAKs) 
subgroup of the STE20 kinases have long been thought to regulate the 
cytoskeleton, while the germinal center kinases (GCK) subgroup of the  
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STE20 kinase family activate the mitogen-activated protein kinase (MAPK) 
pathway. The Morris lab identified PSK as the first member of the STE20 
family lacking a Cdc42/Rac binding domain that could regulate both the c-
Jun N-terminal kinase mitogen-activated protein kinase pathway and the 
cytoskeleton.  Three years later, they showed that there are two Tao-1 
homologues in humans, which are called PSK1 and PSK2. Following on 
from this report, they showed that PSK1 alters actin cytoskeletal 
organisation and binds to and stabilizes microtubules; PSK2 which lacks a 
microtubule-binding site, activates c-Jun N-terminal kinase (JNK), and 
induces apoptotic morphological changes that include cell contraction, 
membrane blebbing, and apoptotic body formation in human Swiss 3T3 
cells [137]. By contrast, Mandelkow’s lab later reported an analysis of the 
Tao-1 kinase in human CHO cells when they searched for upstream 
regulators of Par-1/MARK. They showed that MARKK/Tao-1 destabilizes 
microtubules via the activation of MARK/Par-1, which hyper-
phosphorylates the Tau protein, causing it to detach from microtubules to 
reduce microtubules stability [144, 145]. Furthermore, this group identified 
2 novel proteins, Spred1 and Tesk1, as interaction partners for TAO kinase, 
which they propose modulate the cross-talk between actin and 
microtubules [146]. In a functional genomic screen study in Hela cells 
performed by Stephen J. Elledge’s lab, Tao-1 was identified as a regulator 
of spindle-checkpoint signaling via the interaction with the checkpoint  
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kinase BubR1 which promotes activation of the checkpoint protein Mad2 
[139]. Thus far, most of the published work on Tao-1 kinase has been 
done in human cells in culture and with biochemistry. Moreover, taken 
together these papers paint a confused picture of Tao-1’s function and 
mechanism of action. Therefore when I identified Tao-1 as an important 
cytoskeletal regulator in parallel RNAi screens in fly cell lines, I decided to 
explore its cellular and molecular function in detail.  
5.2 RNAi screens across multiple cell lines identify Tao-1 
as a regulator of microtubule organisation 
One of the main goals of my RNAi screen work was to identify novel 
cytoskeletal regulators. Studying gene function using Drosophila cells can 
simplify the research work because there is less genetic redundancy in the 
fly genome compared to the human genome, even though many genes 
are functionally conserved between humans and flies.  In my parallel 
screening work, I identified a set of kinases which have morphological 
phenotypes across all cell lines tested (clustered in C1 group in Figure 3-
6). Tao-1 kinase is one of the strongest hits in this group. Tao-1 RNAi cells 
show strong morphological phenotypes which include a spiky cell shape, 
bundled microtubule filaments and a disorganized microtubule network 
(see Figure 5-1 and Figure 5-2). Similar Tao-1 RNAi phenotypes were 
seen in S2R+, BG3-C2 and Dm16 cell lines, which derive respectively  
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from haemacytes, CNS tissue, and from the Drosophila wing disc.  
This implicates a role for Tao-1 as a core regulator of cell shape across 
different cell types, making research on the tao-1 gene significant. The 
latest release of Flybase predicts the existence of 4 annotated 
transcriptions based on mRNA sequencing data, PA, PB, PD and PE (PA 
and PB encode same polypeptide and are shorter at 2.08kb in length; PB 
and PD encode the same peptide but are longer at 4kb in length). PA and 
PB don’t encode a kinase domain, whereas PD and PE encode a 1039 
amio acid mutipeptide that contains the conserved serine/threonine kinase 
domain which was identified in the human protein. My analysis is based 
on the long PD and PE transcripts.  
During the course of my RNAi analysis I used two sets of primer pairs to 
target different regions of the Tao-1 PD and PE transcripts (one pair target 
the N-terminal kinase domain and the other target the C-terminus) in order 
to confirm that the phenotype identified in the screens was not the result of 
an off-target-effect (primer sequence information can be found in the 
additional file 4). Both dsRNAs showed the same phenotype. Based on 
this analysis, the phenotypes seen in Tao-1 RNAi cells are likely to be real 
and caused by the loss-function of the PD and PE Tao-1 mRNA.  
To confirm the Tao-1 knockdown in each cell line, I had custom antibodies 
made for this purpose by Eurogentec. A rat monoclonal peptide antibody  
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was generated against the C-terminal part of Drosophila Tao-1 : 967-981: 
C+FNQERAERLRMKHEK-CONH2[144] and a rabbit multipeptide 
antibody was generated to recognize the phosphorylated form of the 
highly conserved T-loop phosphorylation site CONH2-
RAQRATS[P]NVFAMC+3 [96]. For unknown reasons, the C-terminal anti-
Tao-1 antibody didn’t work in Western blots although it worked in 
immunoflourescent staining. Nevertheless, the P-Tao-1 antibody worked 
for both western blotting and immunoflourescent staining. The Morris lab 
[141] used our P-Tao-1 antibody to show that it also recognises human 
PSK1/2.  
I then used P-Tao-1 to test the extent to which Tao-1 protein was knocked 
down following RNAi. In extracts from control cells, the P-Tao-1 antibody 
identifies a protein of 120KD which probably corresponds to PD and PE 
(see Figure 5-1 b). For this analysis I used a P-Moesin antibody as a 
loading control, since I suspected that Tao-1 RNAi might affect α-Tubulin 
or actin levels. I checked the protein bands with Ponceau after the gel 
transformation and they correspond in levels to the bands revealed by P-
Moesin. I decided to use a cocktail of phosphatase inhibitors (I+II) to 
inhibit the dephosphorylation during the lysis of RNAi treated cells, as 
phosphorylated Tao-1 is likely to be unstable in the cell extracts. Analysed 
in this way, quantification of the western blot gel picture shows that the  
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RNAi treatment reduced the levels of endogenesis Tao-1 by ~75-80% (see 
Figure 5-1 c).  
 
To know more details of the Tao-1 RNAi phenotypes, confocal images 
were also obtained. This revealed that microtubules accumulate in 
bundles in spiky Tao-1 RNAi cells and become very straight. Moreover, the 
microtubule network loses its normal organization in Tao-1 RNAi cells (as 
Figure 5-1 Parallel screening in 3 different cell lines demonstrates 
Tao-1 has strong microtubule phenotypes. a. Images from 
automated screen for S2R+, BG3-C2 and Dm16 cell lines 
demonstrate that Tao-1 silenced cells have  strong microtubule 
phenotypes (cell stained with Dm1α (sigma) antibody 1:500). b. 
Westernblot with P-Tao-1 antibody staining confirms the efficiency of 
Tao-1 silencing. c. Quantification of Westernblot bands using P-Moe 
as loading control. 
b 
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shown in Figure 5-2 a). Quantification of levels of protein knock-down (see 
Figure 5-2 b), show that the Tao RNAi worked very well.  Based on all 
above, these data suggest that Tao-1 kinase plays an important role in the 
regulation of microtubule organization. However, it is still not clear how 
Tao-1 functions as a microtubule regulator.   
 
5.3 Tao-1 regulates cell morphology by destabilizing 
microtubules 
The fact that Tao-1 RNAi generates microtubule bundles, suggests that 
Figure 5-2 Tao-1 RNAi 
phenotype in S2R+ 
a. Confocal images of Tao-1 
RNAi treated S2R+ cell 
demonstrate MT phenotypes 
(1:500 Dm1α antibody stain used 
to visualise MTs); b. 
Quantification of Tao-1 RNAi 
positive cells shows about 78% 
cells has these phenotypes. 
Three independent replicates 
were used to generate the error 
bar. 
a 
b 
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Tao-1 may function as a microtubule destabilizer. As a further study of this 
hypothesis, I decided to test the effects of Tao-1 overexpression in 
Drosophila cell lines. Using Drosophila gateway cloning system, I 
generated a GFP/RFP tagged full length Tao-1 which has the fusion 
protein at its N-terminus (see methods and materials). The reason I chose 
to fuse GFP/RFP at its N-terminus was to avoid perturbing its microtubule 
binding activity, which has been reported to reside in its coiled coil C-
terminal domain [137]. As expected, in contrast to the Tao-1 loss-of-
function phenotype, Tao-1 over-expression resulted in the loss of 
microtubules. Interestingly, in Tao-1 over-expressing cells microtubules 
filaments fail to reach to the cell edge of interphase S2R+ cells (see 
Figure 5-3 top panel). Similarly, in GFP-Tubulin-S2 cells, overexpression 
of RFP-Tao-1 clearly limits microtubules to the perinuclear region and 
reduces the microtubule network (as shown in Figure 5-3 bottom panel). 
27 out of 30 transfected S2R+ cells quantified displayed this phenotype. 
The remaining 3 cells in my quantification which had a normal microtubule 
distribution, might have expressed lower levels of GFP-Tao-1. 
Unfortunately, I could not find many cells in mitosis with GFP-Tao-1 
overexpressed to confirm the effect of overexpression of Tao-1 on the 
mitotic spindle probably due to the low mitotic index combined with 
moderate transfection efficiency. Nevertheless, so far, I know that in 
interphase Tao-1 RNAi appears to increases the microtubule filaments  
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while overexpression of Tao-1 can destroy the microtubule network. These 
data suggest that Tao-1 could function to destabilize microtubules in 
interphase Drosophila cell lines. 
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5.4 Localisation of Drosophila Tao-1 
The localization of a protein can often help strengthen the understanding 
of its function and mechanism of action. Hence, I studied the localisation 
Figure 5-3 Overexpression(OE) 
of Tao-1 causes MT network 
disassembly in both S2R+ and 
S2 cells.  
(The Y-axis represents the 
number of cells and the error bar 
is calculated from 3 times 
quantification replicates.) 
Top panel demonstrates GFP-
Tao-1 OE phenotypes in S2R+; 
bottom panel demonstrates RFP-
Tao-1 OE phenotypes in GFP-
tub S2 cell (a. shows GFP-Tao, 
a’ shows MT channel and a’’ 
shows merged image with a and 
a’; b shows GFP-α-Tub channel, 
b’ shows RFP-Tao, b’’ is merged 
images with both b and b’).Note: 
The red signal in the other cells 
is background due to increased 
gain used to see the cell edges.  
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of Tao-1 using anti-Tao-1 multipeptide-antibody which recognizes the C-
terminal part 967-981: C+FNQERAERLRMKHEK-CONH2 and GFP-Tao-1 
in S2R+ cells.   
 
As I mentioned above, this non-phospho-Tao-1 antibody didn’t work for my 
westernblot, but it works for the immunoflourescent staining. The level of 
Tao-1 protein was assessed in Tao-1 RNAi cells and control LacZ RNAi 
treated cells, 5 day after dsRNA addition (see Figure 5-4). The results 
Figure 5-4 Tao-1 antibody reveals Tao-1 colocalises with MTs and 
reveals that RNAi works because the signal of the immunoflourescent 
staining in Tao-1 RNAi cells was lower than that of control S2R+ cells 
when using the same settings.  
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show that the antibody works for immunoflourescent staining and confirms 
the efficacy of the RNAi. The results also show that Tao-1 is weakly co-
localized with microtubules and can also be seen at the cell cortex in 
interphase. This is most clear in Figure 5-5.   
 Interestingly, using the Tao-1 antibody I also found that endogenous Tao-1 
co-localises with the mitotic spindle in mitotic cells (see Figure 5-6). In 
addition, I was able to compare the localization of both endogenous and 
GFP-tagged Tao-1 using this antibody. GFP-Tao-1’s localization in mitotic 
S2R+ cells confirmed the Tao-1 antibody staining result (Figure 5-7), and 
Figure 5-5 Tao-1’s localisation in interphase S2R+ cells.  
Panels demonstrate that Tao-1 is co-localized with MTs and at cortex. 
a. shows MTs stained with in 1:500 α-Tubulin; a’ shows Tao-1 antibody 
staining; a’’ shows merged image. Bottom panel reveals the 
localization of GFP-Tao over-expressed in an S2R+ cell. b shows 
GPF-Tao b’ shows MTs; b’’ is merged image for both.  
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suggests that GFP-Tao-1 is likely to function normally in these cells. In this 
experiment, I used phospho-Histone H3 as a marker of mitotic 
chromosomes (see Figure 5-7). The failure of the chromosomes to align 
suggests that Tao-1 overexpression may perturb mitosis, as suggested by 
Elledge ‘s lab [139]. Since I didn’t find any more mitotic cells transfected 
with GFP-Tao-1, I decided to leave the analysis of Tao-1 in mitosis to the 
future. 
 
Figure 5-6 Tao-1 colocalizes 
with the spindle in mitotic 
Drosophila S2R+ cells. 
DM1α was used to stain MTs in 
1:500 concentration followed 
by 1:2000 TRITC secondary 
anibody; Anti-Tao-1 antibody 
was used to stain endogenous 
Tao-1 in 1:1000 concentration 
followed by 1:1000 FITC 
secondary antibodies.  
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Taken together, these data show that Tao-1 colocalises with microtubules 
in interphase and in mitotic stage. In interphase, it seems Tao-1 is also 
localized at the cell cortex. These results support the RNAi and 
overexpression results which suggest that Tao-1 has an effect on 
microtubules. 
Figure 5-7 GFP-Tao-1 colocalizes with the spindle in mitotic S2R+ 
cells and may disturb chromosome segregation.  
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5.5 Molecular and cellular biological function of Tao-1  
5.5.1 Tao-1 regulates microtubules organization via it kinase 
domain 
By using the bioinformatics database SMART (http://smart.embl-
heidelberg.de/ ) I analysed Tao-1’s functional domains based on its protein 
sequence. Drosophila Tao-1 has a typical serine/threonine kinase domain, 
an ATPase domain, an ERM-like domain and three repeated coiled coil 
domains, moving from the N to the C-terminus. Based on this structure, I 
began by studying the function of its kinase domain, since previous works 
suggested that human Tao-1 homologue-PSK regulates cell morphology 
through its kinase domain [138]. By comparing the Tao-1 sequence with 
the PSK sequence I identified K56 as a conserved residue in the catalytic 
core of the kinase domain, and introduced a point mutation to change this 
Lysine (K) to an Alanine (A), which would be expected to generate a 
kinase dead Tao-1. This could cause a dominant negative effect indirectly 
by sequestration of its substrates. It was also tagged with either GFP or 
RFP at its N-terminus (see methods and materials).    
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Overexpression of RFP-K56A Tao-1 in S2R+ cells results in a very similar 
phenotype to seen in loss-of-function of Tao-1 RNAi cells (Figure 5-8), with 
an accumulation of microtubules in bundles, microtubule spikes and a 
disorganized microtubule network (all 11 of the cells quantified in this 
experiment showed this phenotype.)   
Figure 5-8 Overexpression of 
K56A kinase dead mutation 
causes a loss of function 
phenotype in S2R+ cells. 
Note that the RFP-K56A 
concentrates at the tips of 
many microtubule-based 
protrusions.   
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To confirm this requirement for the kinase activity for Tao-1 function, I also 
generated another mutation, GFP-delta-51-345-Tao-1, in which the N-
terminal kinase domain was deleted. Once again, this had dominant 
negative effects on cell morphology in 6/6 randomly identified transfected 
cells in this experiment. Since Tao-1 can bind to itself in a yeast two hybrid 
analysis, as shown in the following section, it is possible that the 
overexpression of GFP-delta-51-345-Tao-1 leads to the similar 
phenotypes as the kinase domain point mutation (see Figure 5-9) because 
it sequesters active Tao-1 by forming heterodimers. This is something I 
plan to test in the future.  
Another interested observation from this experiment was the fact that 
RFP-K56A can be seen concentrating at the cortex and at the tip of each 
microtubule-based protrusion. This raises two possibilities: First, Tao-1 
could stay and wait at the cell cortex for growing microtubule plus ends to 
Figure 5-9 Overexpression of GFP-delta-51-345 results in dominant 
negative Tao-1 phenotypes. 
a. shows GFP-delta-51-345 channel; a’ shows microtubule staining 
with DM1α; a’’ shows the merged image  
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stop them by inducing catastrophe. When K56A is overexpressed in the 
cell, microtubules are not able to be stopped when they hit the cell cortex 
as usual, leading to the dominant negative phenotype and to the further 
recruitment of Tao-1 to the local area as observed. The second is that 
inactive Tao-1 could function as microtubule plus end tracking protein. 
These ideas will be explored further in the following sections. However, all 
the above data confirm that Tao-1 functions as a microtubule destabilizer 
via its kinase domain. 
5.5.2 The ERM-Like domain of Tao-1 is necessary for the 
formation of lamellipodium and cell spreading   
Recently, we found that Drosophila FERM protein, moesin, is necessary 
for the increase in cortical rigidity and cell rounding when cells enter 
mitosis, and that overexpression of the phospho-mimetic activated form of 
moesin causes cells to round up and stop the formation of lamellipodia 
[99]. This raised my interest in ERM proteins. In general the FERM 
domain proteins bind to the sides of actin filaments and regulate cell 
morphology by cross-linking actin filaments to the plasma membrane [147].  
When looking at the Drosophila Tao-1 amino acid sequence using the 
protein domain prediction database SMART (http://smart.embl-
heidelberg.de/ ) I identified a putative ERM domain within a putative 
ATPase domain. I therefore wanted to know what this domain might do. A  
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RFP fused mutation Delta-422-900 Tao-1 was designed and generated. I 
then expressed the non-ERM mutant Tao-1 in S2R+ cells.  The 
overexpression of the ERM-like domain deletion mutant delta-422-900-
Tao-1 (see method and materials and Figure 5-10) prevented cells forming 
large lamellipodia and spreading as usual. 
Moreover, the microtubule network appeared completely destroyed in 7/7 
randomly picked cells in which RFP-delta-422-900-Tao-1 had been 
overexpressed. This phenotype was much stronger than that seen when 
full length Tao-1 was overexpressed. As a simple test of whether this 
dramatic effect on microtubules is likely to be direct or via a Drosophila 
specific pathway, I decide to repeat this experiment in human cells. I used 
Hela cells for this purpose. Hela cells are big and have nice big 
lamellipodia when completely spread. I subcloned this ERM-like deletion 
mutation of fly Tao-1 into a human gateway expression vector pDEST-YFP 
Figure 5-10 Overexpression of RFP-delta-422-900 stops cells spreading 
while the microtubules are completely destroyed. 
b is Mts stained with Dm1α followed FITC; b’ is RFP-delta-422-900-Tao-
1; b’’ is merged image  
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(a gift from Michael Wer in Nic Tapon’s lab). Overexpressing pDEST-YFP- 
delta-422-900-Tao-1 in Hela cells had a very strong phenotype as shown 
in Figure 5-11. YFP positive cells overexpressing delta-422-900-Tao-1 
were prevented from generating lamellipodia and from spreading like 
control cells (see Figure 5-10 top panel YFP overexpression only). Again, 
the microtubule netwoks appeared completely disassembled when 
compared to a control cell which overpexpressed YFP alone. This result 
suggests the possibility that Tao-1 may have a more or less direct effect 
on microtubule stability or dynamics. There are several reasons why this 
mutated version of the kinase may have an overexpression phenotype 
which is much stronger than that of the active full length kinase. First, it 
suggests that in the context of full length Tao-1 a part of this domain limits 
Tao-1’s activity. Since ERM domains enable proteins to bind to F-actin 
[148], it is possible that the stronger microtubule phenotype seen in this 
experiment is due to the release of an inactive pool of Tao-1 from the cell 
cortex. If so, the functional kinase part can still work and the strong 
phenotype may result from the increase of functional protein levels in the 
cytoplasm. Alternatively, the deleted ATPase domain may have some 
function. Finally, since the deleted domain also contains a nuclear 
localisation sequence, this region of the protein may be required to 
sequester active Tao-1 in the nucleus. I will discuss this further in the Tao-
1 signaling section. This analysis also proves that Drosophila Tao-1 has a  
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conserved function.  
 
5.5.3 Coiled-coil domains enable Tao-1 to associate with 
centrosomes and microtubules 
As I mentioned above, Drosophila Tao-1 has 3 repeated coiled coil 
domains at its C-terminus, which are supposed to help Tao-1 bind 
microtubules and which are required for its function [96, 137]. To test this, I 
Figure 5-11 Drosophila Tao-1 can stop cell spreading and lamellipodial 
formation in Hela cells, and destroy the microtubule network 
Top panel: YFP was used as a control to overexpress in Hela cell  
Bottom panel: Delta-433-900 Tao-1 expression.  
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generated a construct in which are three coiled-coil domains from 900 to 
1039 amino acid  at the C-terminus of Tao-1 are deleted (the stop codon 
was replaced during the subcloning work). Overexpression of RFP-delta-
900-1039-Tao-1 shows that it doesnt remain in the cytoplasm or associate 
with microtubules and centrosomes any more (see Figure 5-12).  
Instead, almost all RFP-delta-900-1039-Tao-1 localises in the nucleus. 
Thus, the coiled-coil domains help to give Tao-1 its functional localization, 
perhaps through binding microtubules. In addition, the microtubule 
network looks normal when RFP-delta-900-1039-Tao-1 display their 
localization in the nucleus, suggesting that the Tao-1 kinase domain 
cannot perform its function when Tao-1 localises in the nucleus. This 
change of localisation when deleting Tao-1’s coiled-coil domains raised my 
interest as the full length Tao-1 is seen in the nucleus and cytoplasm, 
whereas the ERM-like domain deletion mutant Tao-1 protein failed to enter 
the nucleus, as seen by confocal Z mode scanning (I scanned these cells 
Figure 5-12 The coiled coil domain deletion mutant RFP-delta-900-
1039 re-localizes to the nucleus 
c is is MTs stained with Dm1α followed by FITC; c’ represents RFP-
delta-900-1039-Tao-1; c’’ is merged image  
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in a z-stack and the picture showed above is a maximum projection to 
overview the microtubule phenotypes.) Thus it seems possible that Tao-1 
may normally undergo a dynamic change in its localisation which requires 
both the ERM / nuclear localisation sequence and the coiled coil domains 
acting in opposition. Does this have a functional meaning? I will return to 
this topic in the discussion section Chapter 6. 
5.5.4 Tao-1 RNAi can stabilise microtubules 
The Tao-1 overexpression phenotype suggests that Tao-1 functions as a 
microtubule destabilizer. However, more direct evidence is required to 
show the effect of endogenous Tao-1 on microtubules. In order to do this, I 
decided to perform a cold shock experiment followed by 5 day RNAi 
treatment in S2R+ cell, following a protocol used in the Rogers’s lab [23] 
(see methods and materials). The idea was to observe the effect of Tao-1 
on microtubules during the recovery process after microtubules have been 
completely destroyed by cold treatment by comparing the recovery in 
control and Tao-1 RNAI cells. As shown in Figure 5-13, microtubules in 
control cells have disassembled after 2.5 hours 0 degree cold treatment. 
However, the same effect was not seen in Tao-1 RNAi cells. This result 
proves that Tao-1 activity destabilizes microtubules in the face of cold 
shock. Importantly, however during the period of cold shock, Tao-1 RNAi 
cells lost their spikes, restoring the circularly symmetrical shape seen in  
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control cells. After 10 minutes recovery at 25 degrees, however, the shape 
of Tao-1 RNAi cells dramatically changed from symmetrical to spiky as 
microtubules became bundled and straight, while the control cells 
regenerated a normal microtubule organization. This result contains some 
important information. First, it shows that the spiky cell shape in Tao-1 
RNAi cells originates from the effect of Tao-1 on microtubule dynamics. 
Second, it shows that Tao-1 is required to destabilize the microtubules in 
cells, and its removal leads to the formation of microtubules that are stable 
even in the presence of cold shock. Finally, microtubule filaments stop at 
the cell cortex in control cells during their repolymerization, but fail to do 
so in Tao-1 RNAi cells. 
Taking all the above together, Drosophila Tao-1 is likely to function to 
destabilize microtubules.   
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5.6 Tao-1 regulates microtubule organization 
independently of the Par-1/Tau pathway in Drosophila 
S2R+ cells. 
As mentioned at the beginning of this chapter, in human CHO and PC12 
cells MARKKs/Tao-1 has been shown to act as a microtubule destabilizer 
Figure 5-13 Cold shock experiment proves that the Tao-1 RNAi 
phenotypes are derived from MTs rather than the secondary actin 
phenotypes. Further more, it shows that Tao-1 activity destablises 
microtubules. (76% of quantified cells shows the similar phenotype in 
Tao-1 RNAi treat S2R+. N=30)  
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in a pathway involving Par-1/Tau pathway [144], in which the activity of 
MARKK/Tao-1 enhances microtubule dynamics through the activation of 
the conserved serine/threonine kinase MARK/Par-1, which leads to 
hyperphosphorylation and detachment of Tau or equivalent MAPs from 
microtubules. Hence, I wondered whether Drosophila Tao-1 has its 
function via the same pathway.  
In  Drosophila there is only one isoform of Tao-1, and this protein has 
extraordinarily strong effects on microtubule organization. Similarly, there 
is one Par-1 kinase in the Drosophila genome which has been implicated
 
in the regulation of cell polarity [149-151] and in Drosophila axis formation, 
where it helps to organize
 the polarised oocyte microtubule array [151].
   
Thus, to test whether Tao-1 regulates microtubule organization through 
Par-1 pathway I looked for a similar microtubule phenotype in Par-1 loss-
of-function cells.  Par1 RNAi failed to induce a comparably strong 
phenotype in the RNAi screens I carried out in multiple cell lines (data can 
be seen online at http://flight.licr.org/). However, to compare the 
microtubule organization in both Par-1 and Tao-1 RNAi treated cells in 
more detail, I looked at confocal images of both Par-1 and Tao-1 5 day 
RNAi treated cells (Figure 5-14). In Par-1 RNAi cells, there was a marked 
increase in the density of microtubules and microtubules appeared 
straighter than they do in control cells. This phenotype was displayed in  
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73.3% of the randomly picked cells, as quantified by eye (N=30) and 
resembles the phenotype of Par-1 null mutant follicle cells [152]. However, 
the global organization of microtubule network appeared unaffected in 
Par1 RNAi cells.  
Interestingly, previous studies in flies show that microtubules are less 
stable in par-1 mutant cells as confirmed by both microtubule-
depolymerising drug and cold shock experiments [152]. Thus, par-1
 
mutant follicle cells lack
  visible microtubules after short microtubule-
depolymerization drug treatments (5 minutes) while the microtubules in 
control cells are extraordinarily resistant to this drug. Thus,
  Par-1 is 
required to stabilize the microtubules in cells in Drosophila [152].  
However, in my study, Tao-1 shows different a effect on microtubules from 
Par-1.  First, Tao-1 RNAi leads to more microtubules while OE of Tao-1 
results in microtubule disassembly as I showed above. Second, the cold 
shock experiment results show 2.5 hour cold treatment in S2R+ cells is 
not able to lead to the disappearance of the microtubules in Tao-1 RNAi 
cells (under the same condition control cell microtubules have 
disappeared.) while 1 hour cold shock can do so in par-1 mutant clones as 
reported in the reference [152].    
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I also tested whether Tao-1 overexpression can cause destabilization of 
microtubules in Par-1 RNAi cells. If Par-1 is an obligatory downstream 
effector of Tao-1, Tao-1 overexpression should not alter the Par-1 RNAi 
microtubule phenotypes. In fact, the overexpression of GFP-Tao-1 in Par-1 
RNAi treated S2R+ cells induced the disruption of microtubules as shown 
in Figure 5-15 (This effect was seen in 10/10 GFP-Tao-1 positive Par-1 
RNAi cells). To avoid the possibility of an incomplete Par-1 knock-down, I 
verified that non-transfected cells showed the typical Par-1 RNAi 
phenotype.  
Figure 5-14 Par-1 and Tao-1 have distinct microtubule phenotypes in 
S2R+ cells. (These Par-1 phenotype was displayed in 73.3% of the 
cells as quantified by eye. N=30)  
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Moreover, I didn’t find any detectable microtubule phenotypes in tau 
knock-down S2R+ cells, which fits with corresponding data from 
experiments looking at the role of Drosophila Tau in vivo [152].  Below I 
compare the different roles of Par-1 and Tao-1 in Drosophila in order to 
make the relationship easier to understand (Table 5-1). 
 
 
Figure 5-15 GFP-Tao-1 
expression in 5 day Par-1 
RNAi cells can still cause 
microtubule dissembly. The 
result suggests that the ability 
of Tao-1 to regulate 
microtubule dynamics is 
independent of Par-1 in 
S2R+ cells. (This result was 
seen in 10 out 10 randomly 
picked GFP-Tao-1 positive 
cells in this experiment.)  
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  par-1 null mutant cell or 
Par-1RNAi in S2R+  Tao-1 RNAi in S2R+ 
Density of 
microtubules   Increased [152]  Increased 
microtubule 
filaments   straight (my data) 
Bundled rigid 
microtubules fail to stop at 
the cell cortex 
microtubule 
network 
organization 
no effect (my data)  Severely disrupted  
microtubule 
stability   Stabiliser [152]  destabilizer 
Cell shape  Symmetric (my data)  spiky 
Table 5-1 Comparison of the effects on microtubules for Par-1 and Tao-1 
in Drosophila cells  
Taken all together, these data show that Drosophila Tao-1 is unlikely to 
regulate microtubules via the mechanism proposed for mammalian Tao-1 
(via Par-1), even though Tao-1 has the same overexpression effect in fly 
and human cells. How then does Drosophila Tao-1 regulate microtubule 
organization in interphase? 
5.7 Tao-1 changes microtubule dynamic instability  
The data presented above show that Drosophila Tao-1 functions as a 
microtubule destabilizer, and argue against Tao-1 functioning via the Par-
1/Tau pathway in S2R+ cells. It was therefore necessary to clarify the 
mechanism for Drosophila Tao-1 to regulate the microtubule 
polymerization. 
Microtubules are very highly dynamic structures. They grow and retract, 
continually probing the cellular environment. One of the interesting results  
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from the cold shock recovery experiment was that microtubule filaments 
keep polymerizing when they reach the edge of the cell in Tao-1 RNAi 
cells, whereas microtubules undergo catastrophe when they reach the 
cortex in control cells. This led me to wonder whether Tao-1 might act on 
the microtubule plus end. In order to track and analysis the behavior of 
microtubule plus end, I chose GFP-EB1 as a marker to take live images. 
EB1 has been well-known to localize to the microtubule plus-end, and has 
been successfully used to mark the growth of microtubule filaments in 
living cells. Steve Rogers developed a Drosophila cell line stably 
expressing pMT-GFP-EB1, which I got from DGRC (Drosophila Gene 
Resource Center) for this purpose [57]. 
Microtubules undergo dynamic instability in which they undergo rounds of 
growth and shrinkage. GTP-loaded tubulin subunits from the cytoplasm 
are added to this plus ends during microtubule filament growth, and 
microtubules shrink when they loose their GTP-tubulin cap. Recently, 
several studies have identified a third state, pausing, in which 
microtubules undergo no significant growth or shrinkage in cells [153-155] 
(see Figure 5-16), which likely represents a symptom of a change in the 
microtubule’s dynamic state. Thus, Hiroyuki Ohkura’s lab found evidence 
to support the hypothesis that mini spindles is an antipausing factor that 
can work as either a microtubule stabilizer or destabilizer [46].   
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I reasoned that by investigating the effect of Tao-1 on the dynamic state of 
microtubules would certainly help me to understand its function. Thus, I 
tracked and measured about 300 microtubule plus ends in different cells 
made visible using GFP-EB1 under several conditions including control 
cells, cells expressing Tao-1, a kinase dead K56A-Tao-1, or Tao-1 RNAi 
cells. Part of work was carried out with the help of Remigio Picone, 
another PhD student in the Baum lab, who developed a script for Image-j 
enabling the automatic recognition and thresholding of the cell edge. I 
then tracked GFP-EB1 comets manually. Remigio Picone also generated 
the plots in Figure 5-16 and Figure 5-17 using ‘R’ program and data 
generated through my analysis. The results of this experiment proved 
informative. Firstly, in control cells, two groups of microtubules were 
identified by the growth rate distribution. A slow group and a fast group. 
Interestingly, the growth speed of a microtubule filament was related to its 
Figure 5-16 Three different states of microtubule instability.  
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location. Microtubule plus ends in central parts of the cell grew faster than 
those at the edge (see Figure 5-17). This could be due to some factors 
which regulate microtubule plus ends that are located at the cell edge, 
which send a signal that restricts peripheral microtubule growth to 
maintain the normal cell shape.  
I then studied microtubule dynamics in cells following perturbation of Tao-1 
function. In this way, I could determine how Tao-1 affects microtubule 
dynamics.  Following the overexpression of K56A-Tao-1 or in Tao-1 RNAi 
cells, the distribution of microtubule plus end growth speeds merged to 
Figure 5-17 Microtubule growth speed can be divided in to two groups 
depending on the location. 
Left graph demonstrates the different distributions of EB1 velocity 
depending on the location 
Region highlighted on up right panel corresponds to MTs in rim of cell 
while the down right panel shows the central region (The actual data 
for this analysis has been put in the additional file 10.)  
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form one large group instead of the two distinct groups seen in control 
cells (see Figure 5-18). In other words, a loss of Tao-1 function causes 
microtubule plus ends to become blind to their location. This is due both to 
the slowing down of central fast growing microtubules, perhaps due to the 
increase in microtubules and the concentration reduction in tubulin, and to 
an increase in the speed of peripheral microtubules. Conversely, the 
overexpression of Tao-1 led to a marginal reduction in the speed of both 
peaks (see Figure 5-18). The mild effect may be due to the effects of any 
increase in microtubule depolymerization being countered by the increase 
in the level of tubulin monomers. It would be interesting, if challenging, to 
test the effects of the hyperactive ERM-like domain deletion mutant Tao-1 
in a similar way.  
Taken all together, these results show that Tao-1 can destabilize 
microtubules and is required for microtubules to undergo a change in 
speed/pause rate at the cell periphery. This is the first report of a kinase 
altering microtubule plus end dynamics at the cell periphery. 
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5.8 Tao-1 can regulate the growing plus end of 
microtubules at the cell cortex 
The dynamic analysis shows that Tao-1 may act at the cell periphery. 
Moreover, one of the important microtubule phenotypes in Tao-1 loss-of-
function cells is that long bundled and straight microtubule filaments push 
on the cell membrane to generate a spiky cell shape. The simplest 
hypothesis to explain this phenotype is that Tao-1 works as a signal 
protein at the cell cortex to let the growing microtubule filament know their 
spatial information. To test this hypothesis there are 2 questions need to 
be answered: 
1)  Does Tao-1 localize at the cell cortex?  
2) Does Tao-1 regulate the growing plus end of microtubules at the 
cell cortex?  
Although my studies on Tao-1 localization suggested that a portion of 
cellular pool of Tao-1 is concentrated on the cell cortex, this effect is a 
frequent artifact of the folding of the cell edge for cytoplasm proteins. To 
get around this problem and to clarify the cortical localization of Tao-1, I 
turned to an analysis in the fly. I crossed homozygous UASp-GFP-Tao-1 
flies to heatshock Gal4 flies to induce the expression of GFP-Tao-1 in vivo. 
I checked the localization of GFP-Tao-1 in the egg chambers where Tao-1  
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localization can be seen in a 3D tissue context.  I also tried to use Tao-1 
antibody to observe endogenous Tao-1, but was unable to determine the 
localisation of the endogenous protein. 
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As shown in Figure 5-19, I found that GFP-Tao-1 was concentrated on the 
cell cortex in vivo. Further more, Tao-1’s localization in follicle cells could 
be disrupted by feeding Latrunculin B containing food to the flies for 24 
hours. Latrunculin B inhibits actin polymerization and disrupts 
microfilament organization. This result implies that in vivo Tao-1 binds to 
actin at the cell cortex rather than microtubules. To confirm this, I carried 
out a similar experiment using RFP-Tao-1 transfected S2 cells (see Figure 
5-20 top panel).  Again the Tao-1 signal at the cell cortex was gone within 
1 minute following the addition of 0.25 μg/ml Latrunculin B. In another 
experiment, I added Latrunculin B (0.25 μg/ml) to GFP-EB1 expressing S2 
cells to test the behaviour of microtubule plus ends in cells lacking Tao-1 
at the cell cortex (see Figure 5-20 top panel). After 10 minutes, single 
microtubule filaments failed to stop at the cell cortex anymore. Instead 
they continued to grow without undergoing catastrophe. Eventually, the 
loss of actin and Tao-1 from the cortex led to a Tao-1 loss-of-function 
phenotype, suggesting that in cells in culture Tao-1 may function as part of 
the actin cortex to induce microtubule catastrophe.  
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In summary, Tao-1 localizes at the cell cortex in vivo and in vitro. Tao-1’s 
cortex localization can be removed by disrupting actin structure in vivo and 
in vitro. Microtubule filaments fail to stop at the cortex when Tao-1 comes 
off from the cell cortex and in Tao-1 RNAi cells. 
 Here, there is also a possibility that this effect is dependent on cortex 
tension when actin structure was disrupted. So, the microtubule filaments 
keep on their growing because there are no forces to make them bend to 
undergo force-induced catastrophe [156]. To test if this is the case, I 
repeated the Latrunculin B experiment and took the live image using Total 
Internal Reflection Fluorescence microscope (TIRF). Using TIRF allowed 
me to take images at a height that is 90nm above the level of the slide, i.e. 
at the exact bottom of the cell. So, any GFP-EB1 dots recorded in this 
image represent the microtubule plus ends which are hitting the cell cortex 
and/or sliding along the bottom cortex of the cell. At the same time, the 
glass bottom of the dish acts like a wall that blocks microtubule growth. 
The aim of this experiment was to test whether the presence of Tao-1 
bound to actin at the cell cortex is required to regulate the dynamics of 
microtubule plus ends in the absence of a change in the physical 
properties of the cortex as experienced by microtubule tips (since they hit 
the glass). I compared the GFP-EB1’s movement at the cell cortex before 
and after adding Latrunculin B using TIRF in live movies. To visualize  
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microtubule dynamics, I combined three sequential pictures from the TIRF 
movie in the different channels of an RGB image to generate a combined 
picture which illustrates the movement of the EB1 comets. A white dot 
therefore is a paused microtubule filament, coloured dots show where the 
position of EB1 has changed in during the time course (Figure 5-21).  
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 This quantification shows that while many GFP-EB1 dots pause at the cell 
cortex before drug treatment (white), most GFP-EB1 dots appear to move 
between timepoints after the addition of Latrunculin B. While this might 
suggest that Tao-1, actin filaments or other actin associated factors are 
Before adding 
LatB
After adding 
Figure 5-21 When actin structures are disrupted by LatB using TIRF 
microscope microtubule plus end become more dynamic and less 
EB1 dots stacked at cell cortex. By superimposing three sequential 
pictures from a TIRF movie in the different channels of an RGB 
image I illustrate the movement of EB1 dot before and after LatB 
treatment. A white dot means no change, blue, red and green dots 
appear when the position of EB1 dot has changed.   
151
required to induce cortical microtubule catastrophe, independently of 
physical force, it is also possible that the cortex is frictionless in the 
absence of the actin cortical mesh, allowing microtubule plus ends to slide 
when they hit the membrane and the glass.  If Tao-1 could be bound to the 
membrane in this experiment, however, I would be able to tell whether 
Tao-1 on the cortex can induce microtubule catastophe in the absence of 
actin.  
Taken together, I think the answer for the first question is clear, that Tao-1 
is on the cell cortex (dominant negative Tao-1 especially so). Furthermore, 
it seems likely that Tao-1 plays a role in helping microtubule plus end to 
know their location with respect to the cortex and to regulate their dynamic 
behavior appropriately.  
Next, in order to test whether Tao-1 also changes the rate of catastrophe 
as microtubules hit the cell cortex, I took the advantage of GFP-EB1 
stable S2 cell line to enable measurement of the life time of visible GFP-
EB1 comets in interphase cells. Using images taken every 2 seconds I 
calculated the length of the time between the moment a GFP-EB1 tip hits 
the cell cortex and when it disappears to estimate the life-time of the 
growing microtubule filament by counting the number of frames between 
the first image when microtubule plus end contacts the cell membrane and 
last image when the GFP-EB1 disappeared. Using these data allows me  
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to test for statistical differences between the life time of a growing 
microtubule plus at the cell cortex in control cells, and cells expressing 
K56A-Tao-1 or  and full-length Tao-1. The analysis showed that the 
survival time of a growing microtubule filament hitting the cell cortex in a 
K56A expressing cell, that has less active Tao-1, is significantly prolonged 
compared to a control (>2 fold increased) (see Figure 5-22). This suggests 
that kinase-dead Tao-1 prevents cortex dependent microtubule 
catastrophe. Conversely, overexpression of RFP-full-length Tao-1 slightly 
decreases the life-time of microtubule plus ends at the cortex. Why is the 
effect of Tao-1 overexpression so weak? I think a possible reason could 
be the confounding factor, mentioned previously, which is that the 
disruption of growing microtubules filaments leads to an increase of supply 
of subunits (α-tubulins and β-tubulins) in the cytoplasm, which drive 
filament growth. So the life time of surviving microtubules will not decrease 
too much. In addition, I might have missed catastrophes events which 
happened in less than 2 seconds.  Nevertheless, taken together these 
data suggest that Tao-1 plays an important role during the interaction 
between the microtubule plus end and the cell cortex. Thus, Tao-1 may 
help to induce the catastrophe of a microtubule plus end when it hits the 
cell cortex. Summarizing all these data, the answer for second question is 
yes - Tao-1 does appear to be able to regulate the growing plus end of 
microtubules at the cell cortex.   
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However, the results so far do not reveal the mechanism by which Tao-1 
destabilizes microtubules and stops the growth of microtubule plus end at 
the cell cortex or the downstream substrate(s) for Tao-1. 
5.9 EB1- A potential substrate for the Tao-1 kinase 
It was shown above that the kinase domain is necessary for Tao-1’s 
function. Thus, the next step is to find out the substrate of Tao-1 kinase. In 
order to get at this, I designed a small scale dsRNA library which targets 
mRNAs for all microtubule plus end binding proteins, all known 
microtubule destabilizers, kinesin-8 family members and kinesin-13 family 
members (all genes in this library has been listed in the additional file 6) . 
Figure 5-22 Tao-1 activates 
catastrophe of microtubule plus end 
at the cell cortex. 
a. demonstrates the high dynamics 
of MT filament; b GFP-EB1 S2 cell 
has been used as a model to study 
the life time of EB1 at the cell 
cortex; c.EB1 Life time analysis 
shows K56A largely prolong the life 
time of EB1 in cell when they hit the 
cell cortex; Full length Tao-1 
overexpression causes a slight 
decrease of the EB1 surviving time.  
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Using this small RNAi library I carried out a modifier screen (see methods 
and materials). The aim for doing this experiment was to find potential 
downstream substrates of Tao-1 that may act in opposition to Tao-1 to 
rescue the Tao-1 RNAi phenotypes. 
5.9.1 EB1 RNAi can partially rescue the Tao-1 loss-function 
phenotype. 
In the Tao-1 RNAi modified screen, EB1 silencing was the only hit which 
could partially rescue the Tao-1 RNAi phenotype (see Figure 5-23). EB1 is 
a plus end binding protein that prevents microtubule catastrophe to 
stabilize microtubule growth [157]. It therefore seemed likely that EB1 
RNAi would lead to an increase in the rate of catastrophe countering the 
ability of Tao-1 RNAi to stabilize microtubule plus ends in interphase. If 
this was the case, why didn’t EB1 have a strong RNAi phenotype in S2R+ 
cells, like that of Tao-1 overexpression? In budding yeast, the double 
mutant CLIP170 and EB1 is dead but the fact that the single mutant can 
survive seems imply their function may largely overlap [158]. Moreover, 
previous work has shown loss-function of MAL3p (EB1 homologue in 
fission yeast) and TIP1p (CLIP-170 homology in fission yeast) result in a 
similar defect in polarized morphogenesis [159, 160]. This type of 
redundancy might explain why neither EB1 nor CLIP170 RNAi had any 
obvious morphological phenotype. In fact, the Rogers’s lab recently  
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showed a kinesin-13 family member Klp10A can bind EB1 and induce the 
catastrophe [50].  
 
Although EB1 and Tao-1 could work in parallel, a potential model to 
explain this result could be that Tao-1 specifically inhibits the ability of EB1 
to bind to or to remain bound to microtubule plus ends. Once EB1 has left, 
other microtubule plus end destabilizers like Klp10A will then be able to 
Figure 5-23 Tao-1 RNAi modifier screen identifies EB1 as a hit. EB1 
RNAi can partially rescue the Tao-1 RNAi phenotype in S2R+ cells.  
156
induce catastrophe from the plus end [51]. If this is true, I should see less 
EB1 comets at the cell cortex in Tao-1 overexpression cells.  
5.9.2 Overexpression of Tao-1 can inhibit EB1 binding to 
microtubule plus ends. 
In order to explore if Tao-1 can have its effect on microtubule plus end 
binding protein EB1 at the cell cortex, I used the TIRF microscope to study 
the GFP-EB1 comet density at the cell cortex. The TIRF microscope 
images at the bottom 90nm of the cell cortex.  This analysis showed that 
there are many fewer GFP-EB1 comets existing in RFP-Tao-1 
overexpressed cell surface (see Figure 5-24).  Thus, one function of Tao-1 
may be to inhibit EB1 binding, increasing the rate of catastrophe.  
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Seeing RFP-Tao-1 protein directly by TIFR live imaging also supports the 
idea that Tao-1 is concentrated at the cell cortex.  
5.9.3 Overexpression of EB1 can rescue Tao-1 OE phenotypes. 
To strengthen this hypothesis I then tried the opposite test. I transfected 
RFP-Tao-1 expressed from an Act5c promoter into pMT-GFP-EB1 S2 cells, 
to enable me to co-express both GFP-EB1 and RFP-Tao-1 in parallel, by 
using CuSO4  to control the expression of EB1.  
Figure 5-24 OE RFP-Tao-1 inhibits GFP-EB1 binding to 
microtubules   
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The result is shown in Figure 5-25. Cells were in the M3 media +/- 70nm 
CuSO4  for 24 hours before the fixation. Strikingly, the microtubule network 
looks denser in cells overexpressing EB1 than in a control experiment 
without CuSO4 (shown in the bottom panel). Moreover, whereas RPF-Tao-
1 overexpression disrupted the microtubule network in S2 cells in the 
absence of copper, it did not in the EB1-GFP expressing cells, which look 
Figure 5-25 EB1 overexpression can rescue Tao-1 overexpression 
phenotype. 
Top panel shows overexpression of GFP-EB1 induced by adding 
CuSO4 can rescue OE Tao-1 phenotype 
Bottom panel shows MTs were destroyed when cells overexpress 
Tao-1 alone. 
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similar to adjacent non-transfected cells.  
These data suggest that EB1 could be the effector of Tao-1 or may act in 
opposition to Tao-1, with Tao-1 inhibiting EB1 directly or indirectly, 
preventing it binding the plus ends of microtubules. During early mitosis, 
EB1 is localized to separating centrosomes and associated microtubules, 
while at metaphase it is associated with the spindle poles and associated 
microtubules. During cytokinesis EB1 was strongly associated with the 
midbody microtubules [54]. Interestingly, P-Tao-1 has a similar localization 
in mitosis (see below), supporting the idea that the two proteins 
functionally interact. Moreover, EB1 has several potential phosphorylation 
sites [55, 161],  suggesting the possibility that Tao-1 may regulate EB1 by 
phosphorylation.  
5.10 Y2H screens identify potential Tao-1 interactors 
In order to find out the mechanism of Tao-1 to destabilize microtubules, a 
Y2H screen was carried out by sending the full-length tao-1 construct to a 
commercial company (Hybrigenics). Drosophila Tao-1 (281-1039) has 
been used as the bait fragment to test the interaction against preys from a 
Drosophila whole embryo cDNA library (0-12+12-24). 
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strength of the 
interaction 
CyclinG a 
Khc a 
RNRL a 
S6K a 
MASK a 
Nesprin a 
Tao-1 b 
Khc-73 b 
CG15087 b 
CG6181 b 
Table 5-2 Y2H screen results 
a means very high confidence in the interaction; b 
means High confidence in the interaction 
In the list of genes identified with a high confidence interaction with tao-1, 
several are microtubule binding proteins. These include Khc. Khc is a 
kinesin-1 family member that transports proteins from minus end to the 
plus end of microtubules [162]. However, Khc RNAi did not result in a Tao-
1 knock-down phenotype and didn’t prevent the Tao-1 overexpression 
phenotype. Thus, more work is needed to explore the possible relationship 
between Tao-1 and Khc. But, it is an interesting topic to track down. I will 
also discuss the perspectives work in chapter 6. Similarly, I would also like 
to explore possible links between Tao-1 and Khc-73. Alternatively, this 
could mean that Tao-1 simply binds to regions common to many kinesins. 
Finally, the fact that Tao-1 itself was identified in the Y2H screen as a 
confident hit supports my previous results that overexpression of the 
kinase domain deletion mutant RFP-delta-51-345 Tao-1 causes the 
dominant negative phenotype, implying that the Tao-1 coiled-coil domain 
may interfere with the function of endogenous Tao-1. Again more needs to  
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be done to explore this further. 
5.11 Study of Tao-1 signaling  
Tao-1, a STE20 family kinase, seems work on microtubule plus ends to 
regulate the dynamic instability from the above results. I found microtubule 
plus end binding protein EB1 could be the downstream effector or 
cooperator with Tao-1. However, how cells regulate Tao-1 to realize its 
function is still not clear.  To explore the activation of Tao-1, I used a 
comparison with its human homologues to identify the T-loop 
phosphorylation site on Tao-1, which should label the active kinase [138, 
141], and used it to make a P-Tao-1 antibody. The rabbit P-Tao-1 antibody 
was made based on the sequence CONH2-RAQRATS[P]NVFAMC+3 and 
ordered from Eurogentec. A phosphorylation site point mutant Tao-1 GFP-
S180E construct was also made to study phosphorylated Tao-1’s function 
and regulation. 
5.11.1 Localisation of P-Tao-1 
It is important to know the localization of a protein as well as its function. 
Both P-Tao-1 antibody staining and GFP-S180E show that P-Tao-1 is 
present in puncta at the cell cortex and is concentrated in the nucleus of 
interphase S2R+ cells (see Figure 5-26 and figure 5-27).   
162
 
Figure 5-26 P-Tao-1 antibody staining shows P-Tao-1 can be seen as 
puncta at S2R+ cell cortex and in the nucleus.  
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This is different to Tao-1 localization, suggesting only a small pool is 
phosphorylated. I also observed P-Tao-1’s localization during mitotic stage 
(These data were obtained with the help of Pato Kunda to find out enough 
mitotic stage S2R+ cells). First, in metaphase, P-Tao-1 colocalises with 
the mitotic spindle and is concentrated at centrosomes as shown in Figure 
5-28, as confirmed using a CNN antibody kindly given to me by Jordan 
Raff’s lab. In cytokinesis, Tao-1 was strongly associated with the midbody 
microtubules (see Figure 5-29). As I mentioned above, the localization of 
P-Tao-1 is similar to EB1 during mitosis which supports the hypothesis 
that Tao-1 may work together with EB1 or may directly regulate EB1 by 
phosphorylation. To test this, I have to do the biochemistry work which will 
be discussed in chapter 6.  
Figure 5-27 GFP tagged phospho-mimic Tao-1 GFP-S180E localizes 
to the cell cortex and concentrates in the nucleus which is same with 
P-Tao-1 antibody results. 
a shows MTs stained with Dm1α; a’ shows GFP-S180E.  
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Unfortunately, I didn’t find any mitotic cells overexpressing GFP-S180E 
(the phosphorylation mimetic Tao-1) to enable me to visualise the 
dynamics of P-Tao-1 during the mitotic stage. P-Tao-1 has been shown to 
be the active Tao-1 [138]. I was also able to show that P-Tao-1 is likely to 
be the active form of the protein because I stained cells expressing the 
hyperactive RFP-delta-422-900 ERM-like domain deletion mutant and 
Figure 5-28 P-Tao-1 colocalizes with mitotic spindle and concentrates at 
centrosomes as confirmed by CNN staining (antibody a gift from Jordan 
Raff).  
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found they are full of phosphorylated Tao-1 (data not shown). 
 
Figure 5-29 P-Tao-1 localisation in mitosis
P-Tao-1’s co-localisation with mitotic spindle and centrosome in 
mitosis (stained with 1:1000 P-Tao-1 rabbit antibody)   
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5.11.2 P-Tao-1 antibody screen results in the finding of potential 
regulators of Tao-1 
As mentioned above, Drosophila Tao-1 is a very high conserved Serine/ 
Threonine kinase. It has a T-loop phosphorylation site which can be 
phosphorylated by upstream kinases. The dsRNA kinase library I made for 
the multiple cell line screens allow me to knock down each different kinase 
in  Drosophila to find out which kinase take the responsibility of 
phosphorylating Tao-1 by detecting the level of P-Tao-1 antibody.  In this 
way, I identified a group of kinases which cause a increase or decrease in 
P-Tao-1 level (see Table 5-3). 
Cell line tested  Gene name   P-Tao-1 antibody level 
S2R+ Bsk  decrease 
S2R+ Tor  decrease 
S2R+ Pp1-87B  increase 
S2R+ Gprk1  decrease 
S2R+ Caki  decrease 
S2R+ Strn-Mlck  decrease 
S2R+ Pi3K68D  decrease 
S2R+ Ipp  decrease 
S2R+ CG3573  decrease 
S2R+ Mekk1  decrease 
S2R+ Slpr  decrease 
S2R+ CG3632  decrease 
S2R+ auxillin  decrease 
Table 5-3 Potential upstream regulator of Tao-1 kinase from kinase-wide 
screen using P-Tao-1 antibody 
In the hit list, bsk and slpr have been known involved in JNK pathway, 
which supports the published data that Tao-1 is involved in JNK signaling 
pathway, as knocking down these two genes lead to the decrease of P-
Tao-1. However, the fact that bsk and slpr RNAi didn’t show a Tao-1 RNAi  
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phenotype suggests that Tao-1’s regulation of microtubules might be 
independent of JNK pathway.  
In cultured mammalian cells, mitogen-activated protein kinase (MAPK) 
pathway is activated in response to a variety of environmental stresses. 
Drosophila MEKK1 is structurally similar to the mammalian MEKK4/MTK1 
MAPKKK.  Drosophila MEKK1 null mutants are hypersensitive to 
environmental stresses, including elevated temperature and increased 
osmolarity [163]. Taken all these results together, it suggests a possible 
role for Tao-1 in the stress response. 
Pi3K68D is one of the subunits of PI3K which is very important cell 
signaling pathway involved in many cell morphogenesis. Recently, our lab 
showed that in the context of acute phosphoinositide 3-kinase (PI3K) 
signalling, dynamic changes in cofilin phosphorylation were found to 
depend [164] on the Ssh phosphatase and then on changes in 
lamellipodial F-actin. It gives a hint that Tao-1 could be also involved in the 
actin regulation in somehow.  
PI3K signaling from Akt to FRAP/TOR targets S6K in Drosophila [165]. 
Tor RNAi leads to the decrease of P-Tao-1’s level. Combined with the 
result from Y2H screen which identified S6K as a confident hit, it seems 
possible that the PI3K-Akt-Tor-S6K pathway is linked to Tao-1’s function. 
All these ideas need be tested further before making firm conclusions  
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though. 
5.11.3 Depolymerization of microtubules causes an increase in 
P-Tao-1 levels 
One more interesting result from my experiments was the finding that 
Nocodazole treatment dramatically increases levels of P-Tao-1 in 
S2R+cells (see Figure 5-24 a), even though it only has a mild effect on 
microtubules. Interestingly the increase of P-Tao-1 is confined to the 
nucleus. Perhaps destroyed microtubules fail to retain P-Tao-1 in the 
cytoplasm and cause the accumulation of P-Tao-1 in the nuclear part – as 
seen with the Tao protein that lacks coiled coil functions. The increase in 
Tao-1 levels was confirmed by western blotting as shown in Figure 5-24 b. 
These data suggest the posibility that microtubule depolymerization may 
activate Tao-1 function while Tao-1 activation may inhibit microtubule 
depolymerization.    
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5.12 Conclusions 
In summary, I have identified Drosophila Tao-1 as a novel microtubule 
regulator that binds weakly to microtubules to inhibit their growth. Tao-1 
functions as a microtubule destabilizer independent of the Par-1/Tau 
pathway. Microtubule dynamic analysis data suggest that Tao-1 has 
effects on microtubule plus ends especially at the cell cortex, while Tao-1 
can bind actin structures at the cell cortex. The loss of an actin filament 
rich cortex may cause Tao-1 to leave the membrane to induce a Tao-1 
RNAi like phenotype in which microtubules fail to stop at the cell cortex. 
Lack of Tao-1 results in increased dynamics of EB1 at the cell cortex and 
fewer catastrophes happened when microtubule filaments hit the edge of 
the cell border. Moreover, P-Tao-1 localization during mitosis is similar to 
Figure 5-30 MTs depolymerization causes a dramatical increase of P-
Tao-1 level in interphase S2R+  
170
that of EB1 as presented in published data [166]. Furthermore, Tao-1 
seems to inhibit EB1 binding to microtubule plus ends and GFP-EB1 OE 
can partially rescue the Tao-1 RNAi phenotype. EB1 has been reported to 
have several potential phosphorylation sites, so could be a substrate of 
Tao-1.  Finally, Y2H screen results and P-Tao-1 kinase screen results 
suggest a group of candidates that could be involved in the Tao-1 
signaling pathway. Taken together, I think it seems likely that Tao-1 is a 
key regulator of microtubule dynamics in interphase and mitotic stage in 
fly cells as it is in human cells.   
These data suggest a novel mechanism by which cells may regulate 
microtubule dynamics by using a localised kinase to regulate the cross 
talk between microtubules and actin structure at the cell cortex. 
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Chapter 6  
Discussion and Future Work 
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6.1 Introduction 
The aims of this thesis were to identify novel generic and cell type specific 
regulators in the signal-transducing cascades that control cell morphology 
using high-throughput RNAi screens in different cell lines with different 
shapes. Through this work, I have identified a core set of kinases required 
for the normal morphology of all cell lines examined, together with kinases 
whose requirement is specific to cell lines with a common tissue of origin. 
This identified a role for minibrain (mnb), a kinase associated with Down’s 
Syndrome (DYRK1A), in the regulation of actin-based protrusions in cell 
lines derived from neuronal lineages. The specificity of this effect was not 
due to cell-origin specific differences in cell shape, since it was cell shape 
independent. In addition, it could not be attributed to differential gene 
expression, since I was unable to find any correlation between gene 
expression and function in this analysis. Furthermore, these screens 
identified an STE20 kinase Tao-1 as a regulator of microtubule plus end 
instability that controls cell shape in all lines tested. Thus, I believe that 
this work has contributed to the understanding of the regulation of cell 
shape in Drosophila and will be useful for people studying the signal 
cascades underlying the cell morphology in the other organisms, since 
these genes are highly conserved in metazoa.    
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6.2 Quality control - A key factor in High-throughput RNAi 
screens 
The mechanism of RNAi can generate sequence-specific off-target effects 
(OTEs), when a siRNA shows significant sequence homology to mRNAs 
other than its chosen target. Sequence specific off target effects can also 
result from activation of the miRNA response, leading to the translational 
repression of off-target mRNAs. Both effects can generate false positives, 
as has been discussed in many studies. In large scale high-throughput 
RNAi screens, this can result in a considerable number of false positives. 
This is thought to be less of a problem when dealing with Drosophila cell 
screens, because the use of long dsRNAs reduces OTEs by summing the 
non-specific effects of each constituent siRNA present at low levels, while 
maintaining silencing of the common target. Although a lot of efforts have 
been made to predict sequence-specific OTEs from sequence data [94], 
the simplest strategy to minimise this problem is to verify that at least two 
dsRNAs targeting different regions of the same gene have the same 
phenotype. If so, then it is likely to be a real phenotype since the chances 
of generating the same off-target effect are usually negligable. In this study, 
I used this strategy to design my screens. Although the 2 libraries didn’t 
complement one another for all genes, about 2/3 of the genes in this 
analysis have been screened at least twice using distinct dsRNAs  
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generated using different oligos. When analysing the results, I found that 
the percentage of hits confirmed as positives in screens using both these 
two libraries was variable, from 79% in BG2 cells to 53% in S2R+ cells, 
which I considered quite poor. This led me to re-test those genes which 
failed to be confirmed by both libraries. For the remaining 1/3 of genes 
that were not covered by the 2 libraries, I estimated a false positive rate 
between 6.7% and 12.5% based on my analysis of a 3
rd dsRNA generated 
from new oligos. It is also very import to select the appropriate positive 
and negative controls in the microscope-based cell morphology assays, as 
a control is needed for each phenotypic class. Multiple negative controls 
enable the evaluation of experimental false positives and facilitate data 
normalisation by providing an estimate of the biological and technical 
variability in the system. This is very important because the data quality 
depends on the screen reproducibility. In summary, my data suggest that 
identifying the false positives caused by OTEs in a high-throughput RNAi 
screen is a key point of quality control which needs to be considered 
before following up the interesting hits. To avoid the artefacts caused by 
OTEs in RNAi screen in vivo and in vitro, it is strongly suggested by my 
work that two oligos or hairpin RNAi targeting different regions of the gene 
of interest should be designed at the beginning of the screening work.  
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6.3 Cell type specific morphological regulator- Mnb  
Using parallel RNAi screens in different cell lines I have identified a new 
CNS-specific cell function for minibrain/DYRK1A, a protein previously 
shown to play a role within both the fly and mammalian CNS, in the 
regulation of the structure of actin-based protrusions. I have also shown 
how this functional genomic approach can be used to differentiate 
between generic and cell type specific gene functions, and to use this 
functional data to cluster cells into groups of lines that are related by both 
origin and morphology. Finally, although these groups resemble clusters 
generated using a gene expression array analysis, my study reveals the 
dangers of using gene expression data to predict function, and in doing so 
demonstrates the importance of cell-type specific RNAi screening as an 
approach for dissecting pathways of cellular control. Moreover, my results 
also suggest that the screen results from one cell type cannot be 
extrapolated to all cell types since some genes have cell type specific 
functions even if they do not have cell type specific expression patterns. 
6.4 Drosophila Tao-1 is a regulator of microtubule plus end 
dynamics at the cell cortex  
In this work, I identified Tao-1 in a series of kinome RNAi screens carried 
out using multiple Drosophila cell lines from different tissues. Tao-1 was 
the kinase with the most pronounced effect on microtubule organisation  
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across all lines tested. In each case, the silencing of Tao-1 caused cells to 
accumulate bundled microtubules. These microtubules fail to stop at the 
edge, pushing on the cell cortex to generate protrusions that give cells a 
characteristically spiky shape, similar to cells that lack cortical actin 
filaments, e.g. Scar RNAi cells [129]. Using S2 cells carrying the GFP-EB1 
marker I showed that microtubules in Tao-1 RNAi cells have a greatly 
reduced chance of undergoing catastrophe when they meet the cortex. 
Significantly, this effect is mimicked by the over-expression of a kinase 
dead Tao-1 or overexpression of a kinase domain deletion mutant, 
demonstrating a likely requirement for Tao-1 kinase activity in the 
destabilization of microtubules. Conversely, Tao-1 overexpression reduces 
the microtubule density, apparently by increasing the frequency of 
microtubule catastrophe.  
Using a stable S2 cell line expressing GFP-EB1, I was able to record the 
dynamics of microtubules plus ends in vivo in the presence or absence of 
Tao-1. These data show an absence of microtubule plus end pausing in 
Tao-1 RNAi cells and in cells expressing the kinase dead mutant variant. 
An RNAi modifier screen identified proteins that might genetically interact 
with Tao-1. EB1 RNAi was the only regulator of microtubule dynamics 
tested that was able to rescue Tao-1 loss-of-function phenotypes. 
Surprisingly, in the opposite experiment, the overexpression of EB1 was  
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able to rescue microtubules following Tao-1 overexpression. These data 
suggest the hypothesis that EB1 and Tao-1 functionally interact. 
 
In summary, as shown in Figure 6-1, I have identified Drosophila Tao-1 as 
a novel microtubule regulator that inhibits the growth of microtubules at 
the cell cortex via their plus end. The key results can be explained by a 
simple model that describes how Tao-1 functions as a microtubule 
destabilizer at the cell cortex to regulator the dynamics of microtubule 
filaments via their plus ends by the inhibition of EB1’s binding (see Figure 
6-2). 
Figure 6-1 A hypothesis based on the data in this study suggests that Tao-1 
regulates MT catastrophes at the cell cortex via its plus end by he inhibition 
of EB1’s binding. Green boxes represent the data already generated, while 
the red boxes indicate the hypothesis that need to be proved; Light blue 
represents the hypothesis resulting from all of the above.   
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In this model, inactive, non-phospho Tao-1 in the cytoplasm could be 
activated by binding actin and/or components of the actin cortex. P-Tao-1 
then induces microtubule plus end catastrophe when the growing 
microtubule filaments hit the cell cortex by inhibiting EB1, perhaps by 
phosphorylation. Active Tao-1 may then be removed from the cytoplasm 
because of the destruction of microtubules, and sequestered in the 
nucleus. Such a mechanism would enable cells to use spatial regulation of 
Tao-1 activity to inhibit the growth of microtubules when they contact the 
cell edge, in which case Tao-1 is playing a role in the cross-talk of 
Figure 6-2 Working models for Tao-1’s role in the regulation of 
microtubule dynamic instability in the interphase cells. Model A shows 
Tao-1 working on the cell cortex to regulate microtubule plus ends via 
EB1. An alternative model B shows the possible way that Tao-1 could 
destabilise microtubules directly, leading to reduced growth and 
reduced EB1 binding.  
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microtubules and the actin cortex. 
An interesting question raised by the above model is: how could Tao-1/P-
Tao-1 change its localization between the nucleus, cytoplasm and the cell 
cortex? My interest in Khc derives from the Y2H screen for Tao-1 
interacters, which identified Khc as a likely Tao-1 partner. Khc is a kinesin-
1 family member, which is responsible for the transport of proteins from 
the minus to the plus end of microtubules [162]. I used Khc RNAi to test 
for functional interactions between the proteins. However, loss-of-function 
of Khc did not result in a Tao-1 knock-down phenotype and the Khc knock-
down failed to rescue the Tao-1 overexpression phenotype (data not 
shown). Nevertheless, in S2R+ cells recovering from cold shock, Khc 
RNAi had a strong microtubule phenotype, causing bundled microtubules 
to accumulate in circular bundles parallel to the cell cortex after a 10 
minute recovery at room temperature (see Figure 6-3). A similar 
phenotype was reported by the Roger’s lab in S2 cells [23]. This suggests 
the possibility that Khc, like Tao-1, controls microtubule stability. More 
works needs to be done to explore the relationship between Tao-1 and 
Khc, for example, by looking at the effects of Khc RNAi on the localisation 
of Tao-1. This will be an interesting topic to follow up.  The other kinesin 
which shows a confident interaction with Tao-1 in Y2H is Khc-73 which 
has been reported to localise at astral microtubule plus ends during  
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mitosis and function in microtubule/Khc-73/Dlg pathway to regulate the 
cell polarity [167]. Thus, Tao-1 could be involved in this pathway by 
interacting with Khc-73. However, the fact that Khc-73 RNAi in interphase 
S2R+ didn’t display a similar phenotype of Tao-1 RNAi might suggest that 
Tao-1 functions at the cell cortex independent of Khc-73 whereas Tao-1 
could play a role in the Khc-73 pathway during mitosis. 
 
A weakness of this working model is its reliance on the localisation of Tao-
1/P-Tao-1's during interphase at the cell cortex. While a population of Tao-
Figure 6-3 Khc RNAi in S2R+ cell causes microtubule phenotypes in 
cold shock recovery experiment.(MTs were fixed by -20 degree cold 
MethOH and stained in 1:1000 DM1α.  
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1 protein appears to be localised to the cortex, Tao-1 is also found in the 
cytoplasm, on microtubules and in the nucleus. Moreover, the 400-900 
deletion mutant appears to be able to remove all MTs regardless of their 
localisation. These observations suggest a possible alternative working 
model.  In this alternative model, Tao-1 could destabilize microtubules 
throughout the cytoplasm in interphase cells. Tao-1 could do this by 
destabilizing microtubules directly, leading to reduced growth and reduced 
EB1 binding, or by inhibiting EB1's binding to microtubule plus ends. It 
remains to be tested which of the two models is correct. 
This analysis also points to complexities in the regulation of Tao-1. First of 
all, as I mentioned in the section 5.5.3, the coiled-coil deletion mutation of 
Tao-1 relocalises to the nucleus. I think there are two possible 
mechanisms responsible for this change in its localization. 1) The nuclear 
localisation of Tao-1 is regulated and loss of the coiled-coil domain allows 
entry into but not export from the nucleus. 2) Tao-1 requires its coiled-coil 
domain to bind Khc, which keeps Tao-1 bound to microtubules in the 
cytoplasm and which transports the protein to the cell cortex. To test these 
two possibilities, I analysed the Tao-1 protein sequence using a database 
(http://cubic.bioc.columbia.edu/cgi/var/nair/resonline.pl) that predicts 
Nuclear Localization Signals. This shows that Tao-1 has a typical NLS 
(MRKFKRKR) beginning at amino acid 725 (see Figure 6-4). In addition,  
182
Tao-1 has a Nuclear Export Signal at L881, based on an analysis using 
the NES prediction tool (http://www.cbs.dtu.dk/services/NetNES/). 
Although the coiled-coil deletion (delta900-1039-Tao-1) retains both 
sequences, it is possible that it may affect the activity of the nearby NES, 
leading to nuclear retention. The presence of an NLS and NES in Tao-1 
suggests the hypothesis that Tao-1 may have a function in the nucleus or 
may be regulated by shuttling between the cytoplasm and nucleus. It is 
unlikely to function in the nucleus however because overexpression of the 
coiled-coil mutant has no phenotype. 
 
 
The other possibility, that Tao-1’s localisation is determined by binding to 
Khc through its coiled coil domain, is supported by the observation that its 
Figure 6-4 Drosophila Tao-1 contains a Nuclear Localization Signal 
MRKFKRKR at No.725 amino acid and Nuclear Export Signal at 
L881 based on the protein sequence prediction.  
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human homologues require the coiled-coil domain to bind to microtubules, 
by the observation that Tao-1 can be seen binding to microtubules in the 
cytoplasm, and by the fact that depolymerisation of microtubules causes 
the nuclear accumulation of Tao-1. If this is the case, it is not clear why the 
NES is not sufficient to maintain Tao-1 in the cytoplasm in the absence of 
microtubules. It may however be a simply matter of the relative rates of 
nuclear import and export. 
Finally, I have shown Tao-1 is released from the cortex of fly cells in 
culture and in follicle cells within the Drosophila germline following the 
treatment with the actin monomer binding drug Latrunculin B. This was 
followed by a reduction in microtubule pausing and the continued growth 
of microtubules at the cell cortex, mirroring the Tao-1 RNAi phenotype. It is 
possible however that this phenotype is due to a protein(s) other than Tao-
1 binding to the actin cortex to regulate microtubule dynamics because I 
don’t have direct evidence to prove that Tao-1 binds to actin and plays this 
function at the cell cortex. This hypothesis is important to test. It would be 
interesting for example to force Tao-1 to bind to the cell membrane to test 
whether this is sufficient to induce the catastrophe of microtubules 
reaching the membrane even in the absence of cortical actin, in presence 
of Latrunculin B. If microtubule filaments still fail to stop at the cell cortex in 
this case, it is likely that Tao-1 is not sufficient to inhibit the interaction  
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between microtubules and the cell cortex. The ability of the cortex to 
induce microtubule catastrophe may require other microtubule regulators 
and/or actin-dependent forces at the cortex. 
6.5 Prospective work and outlook 
In order to test for the mechanism by which Tao-1 regulates microtubule 
dynamics, I plan to carry out a biochemical analysis to test whether Tao-1 
alone is able to inhibit microtubule growth and/or induce microtubule 
catastrophe. To investigate the effects of Tao-1 on the frequency of 
microtubule growth, pausing and catastrophe, I will use the biochemically 
defined in vitro system that the Howard lab has set up and running to 
visualize microtubule growth following the addition of recombinant Tao-1 
protein [2]. I will use TIRF to test the ability of these proteins to bind 
labeled microtubules and to measure the effects of Tao-1 on the kinetics of 
specific steps in the lifetime of a microtubule [1, 2]. By overcoming the 
effects of background fluorescence from free labeled tubulin, this 
technology will enable me to focus my attention of a narrow region very 
close to the coverslip where rhodamine-labeled microtubule seeds are 
anchored. Using this assay, I should be able to calculate the rate of 
microtubules plus end growth in the presence or absence of different 
GFP-Tao-1 variants.  
As EB1 genetically interacts with Tao-1, I will also test whether Tao-1  
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requires EB1 to exert its effects on microtubule dynamics, using a 
recombinant EB1 generated in the Howard lab. I will then be able to 
compare these in vitro results to the in vivo data.  If this proves to be the 
case, I will look for evidence that Tao-1 directly phosphorylates EB1. 
Finally, I will generate a myr-tagged full length RFP-Tao-1, which contains 
a short membrane binding domain sequence. Overexpression of this myr-
RFP-Tao-1 will allow me to observe what will happen when Tao-1 is forced 
to bind to the membrane in the presence or absence of actin filaments. 
This experiment will tell me whether Tao-1 is sufficient to destabilize 
microtubules at the cell cortex or whether it requires other factors. 
Having worked in the Baum lab using RNAi, Drosophila genetics, and cell 
biology to build up a strong genetic and cell biological argument for a role 
for the Tao-1 kinase in the regulation of microtubule dynamics in 
interphase and mitosis, it is important for me to use biochemical assays to 
test these hypotheses directly. I anticipate that the understanding gained 
through these studies will be an important step towards a better 
understanding of microtubule regulation since, when tested using RNAi, 
Tao-1 has the strongest microtubule phenotype of all kinases in the 
genome. Since little is known about the regulators that can switch the 
state of an individual microtubule during the course of its lifetime or the 
regulators that alter global microtubule dynamics during specific phases of  
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the cell cycle, this work on the conserved Tao-1 kinase may have 
important implications for many fields in which cytoskeletal dynamics play 
a role, e.g. axonal pathfinding, cell polarisation and spindle 
morphogenesis.  Furthermore, Tao-1 was found to associate with two 
kinesin heavy chains-Khc and Khc-73 in a 2 hybrid screen, suggesting the 
possibility that Tao-1 kinase may function through interactions with 
kinesins. Alternatively, kinesins may help to transport Tao-1 along 
microtubules, which may explain the dramatic effect of Khc on microtubule 
dynamics [23]. Finally, although direct evidence for phosphorylation of 
EB1 by Tao-1 hasn’t been clearly addressed, this is first time a kinase has 
been found to function at the cell cortex to regulate  microtubule plus end 
stability, and it also suggests a novel mechanism for cell to regulate the 
cross-talk between microtubule filaments and the actin cortex. 
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